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ABSTRACT
The McrBC (Modified Cytosine Restriction) restriction system has the ability 
to restrict DNA containing 5-hydroxymethylcytosine, N4-methylcytosine, and 5- 
methylcytosine at specific sequences. The mcrB gene produces two gene products. 
The complete mcrB open reading frame produces a 53-kDa protein (McrB, ) and a 
35-kDa protein (McrBs). The smaller McrB polypeptide is produced from an 
inframe, internal translational start in the mcrB gene. The mcrC gene produces a 
single 38-kDa protein.
Evidence was presented that McrBs regulates the activity of McrBC. When 
McrBs was overproduced in a McrBC+ background, there was dramatic loss of 
restriction. Underproduction of this protein using antisense RNA caused variable 
restriction and triggered the SOS response indicating extensive DNA damage. Based 
on experimental results, McrBs was found to have distinct interactions with McrC 
and McrBL. A unique assay, termed the restriction rescue assay, was used to 
examine McrBs-McrC binding. Truncated versions of McrBs were used in the 
McrB* assay to provide evidence that McrBs and McrBL bind. In some cases, 
elevated levels of McrB* activity, hyper-restriction, observed in the presence of 
McrBs peptides was accompanied by induction of SOS, slow growth and cell death. 
Based on findings, we propose that the active restriction complex minimally consists 
of a McrBL homodimer. McrBs regulates restriction by binding McrBL to form an 
inactive McrBL-McrBs heterodimer. McrC associates with the active McrB, 
homodimer to form the McrBC endonuclease and with McrBs containing inactive
complexes. Protein-DNA binding studies and in vitro cleavage studies allowed us 
to define specific binding site, cofactor, and subunit requirements for this restriction 
system. Results of these assays suggest that no subunit alone can bind specifically 
to DNA containing methylated Pvull sites. Target DNA fragments containing 
methylated Pvull sites were specifically bound when all three McrBC peptides were 
present whether these linear DNA fragments contained three, two, or one methylated 
Pvull sites.
xii
INTRODUCTION
Restriction-modification systems. Restriction systems function as the 
bacterial equivalent of our immune system. Through these systems, bacteria can 
molecularly monitor the origin of invading or non-self DNA and determine its fate. 
All DNA possesses the same four bases, so the cell must have some additional 
means by which it can determine self from non-self. This is accomplished by means 
of DNA modification in the form of methylation of nucleotides within specific 
sequences. Foreign DNA detected by the bacterium is inactivated by endonuclease 
cleavage (57).
Restriction-modification systems are common among bacteria from all 
ecological niches and taxonomic groups (34). Over 10,000 bacterial strains have 
been examined and approximately one-quarter have been found to contain sequence 
specific endonucleases (34, 37). The fact that higher numbers were not seen to 
possess restriction endonucleases may not be because they are absent, but because 
there is some unforeseen variable, such as abnormal reaction conditions, unusual 
target sequences, infrequent cleavage, excessive exonuclease activity, etc.
In addition to restriction endonuclease activity, these restriction-modification 
systems possess DNA methylase activity that transfers methyl groups from S- 
adenosyl-methionine (AdoMet) to adenines or cytosines at a specific site. Once 
methylated, these sites are now protected from the restriction endonuclease activity 
(81). There are exceptions where the specific endonuclease requires a methylated 
site for cleavage, such as Dpnl.
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Restriction-modification systems have been classified into four types based 
on cofactor requirements, structure, and restriction and modification site specificity. 
There are two types of ATP-requiring enzymes known as Type I and Type III. Both 
require ATP and Mg2+ for restriction, and both consist of a single multifunctional 
enzyme. The Type I restriction activity also requires AdoMet, which is not required 
but does enhance the restriction by Type III systems. Type II systems require 
AdoMet only for methylation and consist of a separate endonuclease and methylase. 
The Type IIs systems are quite similar to the Type II systems except that they 
possess different types of recognition sequences and cleave DNA differently.
Although modification is always sequence specific, some restriction 
endonucleases cut distal to the methylase recognition site. Type II restriction usually 
occurs within the methylation recognition site or the methylation/endonuclease site, 
while Type IIs systems cleave within 20 base pairs (bp) on one side of the 
recognition site. Type III systems cleave 24 - 26-bp to the 3’ side of the host specific 
site and the Type I restriction system’s cleavage site is from several hundred to 
>  1000-bp away from the recognition site and is seemingly random in nature.
Type I restriction systems. To date, all Type I restriction systems have 
been found in the Enterobacteriaceae, such as Escherichia coli B and K, Salmonella 
typhimurium, and Citrobacter freundii. Fewer than a dozen natural Type I 
restriction systems have been discovered. Because no definitive screening method 
exists there may be many more. Throughout these species, this restriction system 
has repeatedly shown to map at similar or even identical positions on their respective 
chromosomes (98.5 minutes on the standard E. coli map) and have been shown to
be allelic (5, 15, 19, 22). The Type I restriction systems are the most complex of 
the four types. They have complex cofactor requirements, cut DNA thousands of 
base pairs from the modification sequence, and are made up of three subunits. The 
Type I restriction system found in E. coli K12 is termed hsd for /?ost .specificity of 
DNA. The genes for this system were designated hsd R, M, and S. These three 
genes occur in this order and are transcribed in the same direction (69). Although 
this is true, two different promoters have been identified. One promoter is 
responsible for hsd R and the other for hsd M and S. This enables synthesis of a 
methylase composed of hsd M and S gene products without the accompanying 
restriction endonuclease. The R subunit is responsible for restriction, the M subunit 
for methylation, and the S or specificity subunit for recognizing the target site of 
DNA. When the S subunit has recognized a target site, the enzyme’s binding to 
DNA may be succeeded either by restriction or modification, which are mutually 
exclusive events. Which action occurs depends on the state of the target site when 
bound by the restriction system. If the target site is fully methylated, the enzyme 
can bind but no further action occurs. If the target is hemimethylated, the enzyme 
methylates the unmethylated strand. If the target sequence is unmethylated, the 
enzyme binds tightly in the presence of ATP, and following DNA translocation, 
cleavage occurs some distance from the recognition site (8, 87). During DNA 
translocation, the restriction complex remains tightly bound to the recognition 
sequence and the DNA loops past this complex in a process dependent upon ATP 
hydrolysis (7, 27, 84, 86). Cleavage is thought to occur when two recognition 
complexes collide and is a two step event where one strand is cut and then the other
strand is cut nearby (47). Recognition complex collision is able to occur because 
DNA translocation is thought to occur in both directions (76). Support for this 
model was obtained by observations via electron microscopy of DNA loops in the 
presence of this enzyme (84). The fact that small circular DNAs are readily cut, 
while linear DNA is poorly cut, would seem to support this model also. What 
selective advantage this cutting at indeterminate distances from the recognition site 
confers is unclear, but this may serve some role in general recombination (56).
The recognition sites for most Type I enzymes are bipartite consisting of a 
specific sequence of three base pairs separated by several non-specific nucleotides 
from a sequence of four base pairs (84). The separation of the two specific 
sequences is such that both lie on the same face of the DNA helix. These two 
sequences possess adenine residues that are methylated on opposite strands when 
modification occurs.
Type III restriction systems. The Type III restriction system is coded for 
by the E. coli prophage P I, the plasmid P15, Haemophilus influenzae of serotype 
Rf, and by Salmonella typhimurium. Each of these enzymes consists of two types 
of subunits. The MS subunit alone acts as a site specific methyltransferase, while 
as a heterodimer with the R subunit, it acts as an endonuclease as well. Each of 
these subunits is coded for by its own gene with its own promoter.
The reaction mechanisms of the Type III restrictions systems are very 
similar. Each requires, but does not hydrolyze, ATP. Non-hydrolyzable ATP 
analogs can substitute, albeit poorly, for ATP in the restriction reaction. Both ATP 
and AdoMet have been shown to serve as allosteric effectors of the enzymes in the
cleavage reaction (85). AdoMet is a restriction stimulant but is not required. The 
presence of both cofactors (ATP and Mg2+), allows Type III enzymes to act as 
methylases as well as endonucleases, meaning that these activities may act 
simultaneously as competing reactions. Once bound to its specific site, this subunit 
competition may result in either DNA methylation or restriction, but it is unclear 
why this is so. Type III recognition sequences are 5 - 6 nucleotides in length, 
asymmetric and uninterrupted. Restriction cleavage occurs 24 - 26-bp to the 3’ side 
of the recognition sequence. This may be because the restriction subunit contacts 
the DNA at this point. Restriction involves staggered cuts, 2 - 4-bp apart. 
Methylation occurs at adenine residues in the recognition site, but only one adenine 
on a single strand is methylated. When replication occurs, one new double strand 
of DNA carries a single methylated adenine, while the other double strand is 
unmethylated and, conceivably, a target for restriction. However, these 
endonucleases require the presence of two recognition sites in opposite orientations. 
Cleavage will occur only if both are unmethylated. Restriction following replication 
is unlikely as one or the other will remain methylated and preserve the host DNA 
from restriction (42).
Type II restriction systems. The Type II restriction modification systems 
are the simplest and most numerous. Over 150 specificities have been identified to 
date (37, 64). This has been the most highly studied group of restriction- 
modification enzymes because of their use in modern molecular biology and 
genetics. The Type II endonuclease requires Mg2+, while the methyltransferase 
requires AdoMet. Both enzymes are able to act independently. In general,
recognition sequences consist of 4 - 6 bases and have two-fold symmetry. Sequences 
can be short or long, continuous or interrupted. The palindromic nature of these 
recognition sites allows one protein to recognize a site on either strand of DNA and 
to cleave both strands of DNA symmetrically. This cleavage may occur on the 5’ 
or 3’ side of the dyad to produce 5 ’ or 3’ single-stranded "sticky" termini, while 
others cleave in the dyad’s center to produce "flush" ends. Methylation also occurs 
symmetrically within the recognition sequence.
Matching methyltransferases and endonucleases virtually always recognize the 
same target sequence, although they each possess separate target recognition 
domains. It is thought that recognition of the same target sequence does not 
necessarily occur when these enzymes first match up, but with time, occurs through 
evolution (81).
Type IIs restriction systems. The Type IIs restriction-modification systems 
are similar to the Type II systems. Both have a Mg2+-requiring endonuclease that 
acts separately from an AdoMet-requiring methyltransferase. The recognition and 
cleavage sites, however, are quite different. The Type IIs recognition sites are 
asymmetric and uninterrupted and range in length from four to seven nucleotides. 
Two-stranded cleavage occurs on only one side of the recognition sequence, and at 
a defined distance (usually under 20-bp) from the sequence, and is usually staggered 
by one to four nucleotides (64, 77).
The amino acid sequences of Type IIs methyltransferase are similar to those 
of the Type II system. The Type IIs methyltransferases probably only differ in that 
they bind asymmetric nucleotide sequences. Since Type II methyltransferases
recognize palindromic sequences and can bind them in both orientations, they 
methylate both strands of the sequence. Type IIs methyltransferases can only bind 
their recognition sequence in one orientation and can, therefore, only modify one 
strand. Because of this, some Type IIs systems have been seen to possess two 
methyltransferases, one for each strand. About 30 Type IIs systems have been 
discovered, but they have not been well characterized. Much is yet to be learned 
about these complex restriction systems.
M ethylation dependent DNA restriction systems. In each of the systems 
mentioned thus far, the DNA is protected from restriction by methylation. There 
are systems that specifically recognize and restrict methylated target sites. It is 
interesting to note that the first restriction systems reported restricted methylated 
DNA (45). It was noticed that certain bacterial strains restricted T-even phage 
mutants that, due to mutations in glucosyl transferases (gt), lacked glucose 
covalently bound to hydroxymethylcytosine in their DNA. These gt mutations left 
the hydroxymethylcytosine-containing DNA (30) exposed to restriction activities 
designated RglA and RglB restriction (restricts glucose/ess phage). Rgl restriction 
was subsequently considered to be an evolutionary relic since at that time no 
naturally occurring wild-type DNA was known to be sensitive to this system (41, 
63). In E. coli, the systems Mrr, McrA, and McrBC recognize and restrict DNA 
methylated at specific sequences.
The Mrr system (modified adenine recognition and restriction) restricts 
foreign DNA bearing N6-methyladenine (32) and at least one sequence bearing 5- 
methylcytosine (36). The M .SM  methylase target is the cytosine of all CG
dinucleotides. This creates a similar modification pattern as that seen in eukaryotic 
DNA and M .to l  modified X phage have been seen to be sensitive to restriction by 
the Mrr system. The newfound activity of mrr to restrict mC containing DNA has 
been designated McrF (37, 41).
The RglA and RglB restriction systems regained importance when it was 
discovered that they decreased the efficiency of transformation by eukaryotic DNA 
(52, 60) and the genes for modification methylases (12, 39). This restriction was 
shown to be sequence specific (60) and modification dependent (52, 60). These 
restriction systems were renamed Mcr restriction (modified cytosine restriction) (60) 
systems, and RglA (now McrA) and RglB (now McrBC) were shown to be two 
separate restriction systems (59). The phrase Rgl restriction has been retained to 
refer to restriction of T-even phage, while Mcr restriction is used to refer to 
restriction of all other methylcytosine containing DNA. The mcr A gene is located 
at 25 minutes on the chromosome of E. coli K12 on the excisable prophage-like 
element e l4  (59). At least three gene products are encoded in e l4  (57), the largest 
of which is likely McrA. The McrA phenotype restricts the T-even phage gt 
mutants (T2, T4, and T6). The T6 gt mutant is most easily used to screen for the 
McrA system as the McrBC system will not restrict this phage (59). The recognition 
sequences used to screen for McrA activity were those conferred by M.Hpall 
(CmCGG) (57) and M.Sssl (mCG) (36).
The McrBC restriction system is located at 99 map units on the standard E. 
coli map (59, 68). This has been designated the immigration control region (59) 
since six different restriction genes are clustered there. Several groups have studied
the McrBC locus and most agree there are two genes producing three gene products. 
The mcrB gene produces 53-kDa (McrBL) and 35-kDa (McrBs) proteins. The 
smaller McrB polypeptide is produced from an inframe, internal translational start 
in the mcrB gene (67). The McrBs sequence is identical to McrBL except for the 
missing 161 amino acids at the N-terminal end (67). Deletions of the N-terminal 
coding portion of the mcrB gene demonstrate that McrBs can be expressed 
independent of the transcription and translation signals for McrBL (67). The mcrC 
gene produces a single 38-kDa protein (24, 65, 66, 67).
McrBC restriction has been reported to be GTP-dependent and the mcrB gene 
contains a motif similar to the consensus GTP binding site (24, 76). ATP was 
reported to efficiently inhibit cleavage. GTP analogues with non-hydrolyzable (3-y 
linkages or mono- or diphosphates do not promote the reaction suggesting a 
hydrolyzable phosphate bond is necessary (76). McrC has been shown to be basic 
via sequence analysis (66).
The mcrB gene alone is sufficient to restrict DNA methylated by M.Mspl 
(mCCGG) or M .to l  (mCG) (23, 24, 36). To measure this activity, the mcrB gene 
was overexpressed using a plasmid. All other sensitive methylation patterns require 
the mcrB and mcrC gene products (23, 24, 66).
Highly purified McrBL and McrC were used in in vitro restriction assays and 
found to confer the same restriction specificity as extracts prepared from mcrBC+ 
cells (76). Using these purified proteins, it was deduced that McrB, and McrC, but 
not McrBs were required for restriction in vitro. No activity was seen for McrB, 
alone even when DNA modified by M.Mspl or M.Stol, which is known to be
restricted by the presence of a functional mcrB gene alone, was used as substrate. 
It is unknown to date, what role McrBs plays, if any, in restriction.
McrBC activity was initially surveyed using targets which all possessed GmC 
or RmC where R indicates purines (60). The McrBC restriction system is known to 
restrict mutant phages T2gt and T4gt, but not T6gt. All three have DNA containing 
hydroxymethylcytosine and it is unclear why T6gt is insensitive to restriction. The 
recognition sequence has recently been proposed to be R"’C (N40.g0) RmC with 
cleavage occurring at multiple positions on both strands (76). DNA with 
appropriately spaced methylated bases on only one strand was sufficient for 
cleavage.
To gain insight into the makeup of the active restriction complex and 
understand restriction of different DNA substrates, different in vivo assays have been 
used. Rgl restriction is defined as restriction of 5-hydroxymethylcytosine (hm5C) 
containing DNA (34, 37) and relies on the presence of both genes (mcrBQ  in the 
host. This assay is performed by using phage T4gt, which possesses lun5C containing 
DNA to infect hosts strains to be tested. Greater host restriction is displayed as 
decreased plaque formation relative to appropriate controls. McrBC restriction is 
defined as the restriction of DNA containing 5-methylcytosine Cn5C) (31, 35). At 
least 14 patterns are recognized, including the pattern methylated by BsuRl. The 
restriction assay consists of either infecting test strains with X bacteriophage which 
contains m5C and counting plaques or transforming these hosts with methylase 
containing plasmids and counting colonies formed. Hosts with this restriction ability 
are mcrBC+. In each case, comparisons are made relative to non-methylated DNA.
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McrB* restriction consists of restriction of m5C-containing DNA also. The mcrB 
gene alone is sufficient to confer this ability and only methylation patterns generated 
by the Msp.I and S.w.1 methylases are restricted. The McrB* assay is performed 
either by infection of host strains with X DNA containing the proper methylation 
pattern or by transformation of the host with plasmids containing the appropriate 
methylase gene, such as M.SPR.
In the present study, the role of McrBs in the McrBC restriction system was 
explored. The effect of increasing or decreasing the in vivo expression of McrBs 
was studied. In vitro restriction activity and DNA binding were also used to 
characterize the McrBC system. Based on the findings of this work, a model 
describing McrBC was proposed.
MATERIALS AND METHODS 
Bacteria, phages, plasmids, growth conditions, and media. The bacterial 
strains, bacteriophage, and plasmid vectors used in this study are listed in Table 1. 
The E. coli strains JM107 (mcrBC+) and DH5aMCR (mcrBC~) share the common 
ancestry of MM294. The ER strains are isogenic. The different plasmids selected 
were used because they had different origins of replication (ori) and were, therefore, 
compatible in the same host. In some cases, plasmids possessing like ori’s were 
used in the same host. In such cases, the plasmids were constructed in such a way 
that they possessed differing antibiotic resistance genes. Strains were subcultured 
in LB broth (48) or on LB 1.5% agar plates. For titering bacteriophage, top agar 
was made using BBL’s trypticase soy broth (0.5%) and 0.8% agar.
Transform ation. Plasmids were introduced into E. coli strains by either 
competent cells produced by CaCl2 treatment (44) or by electroporation (25, 26). 
The former protocol was employed in the McrBC assay that used methylase plasmids 
and the latter method was used to construct plasmid-containing strains.
M crBC assay using methylated X phage. McrBC activity refers to the 
ability of this restriction endonuclease to cleave substrates modified at one of many 
characterized patterns (52, 59). In this study, the methylation pattern GGmCC of 
M.B.swRI was used to represent these patterns. Restriction of this pattern requires 
both McrBL and McrC proteins (23, 24, 54, 66). A 3.4 kilobase (kb) EcoRl 
fragment containing the M.&wRI methylase gene from B. subtilis R was ligated into 
EcoRI cut pBR322. The resulting plasmid was designated pM.B.vuRIlO (39). A vir 
mutant of phage X was used to infect DH5aMCR (pM.&wRHO) and the lysate
Table 1. Bacterial strains, bacteriophage, and plasmid vectors
Bacteria, Plasmid 
Vector or Phage
Bacterial strains
ER1564
ER1648
ER1381
JM107
DH5c*MCR™
Bacteriophage
Xvir
T4
T4 gt 
Plasmids
pBR322
pACYC184
pUC18/pUC19
pA R V ll
Relevant Features
mcrA, mcrBC+, Tetr, hsd, 
mrr
mcrA, mcrBC, Tetr, hsd, 
mrr
mcrA+, mcrBC+, Tetr, hsd 
mcrA, mcrBC+, hsd 
mcrA, mcrBC, hsd, mrr
vir
wild-type
gt (non-glucosylating)
Apr, Tcr, Col El 
origin of replication
Cmr, Tcr, p l5a ori
Apr, rop, Col E l ori
Antisense RNA 
synthesis vector
Reference
(60)
(60)
(60)
(83)
(10)
(71)
(30)
(30)
(14)
(20)
(83)
This study
containing M.Zta/RI methylated X was collected and used to assay McrBC restriction 
(60). Efficiency of plating (EOP) was determined by dividing the number of plaque 
forming units (pfu) obtained when infecting strain X with methylated X by pfu 
obtained when infecting the permissive host DH5aMCR (pBAB99) with the same 
phage. For a given strain, restriction was calculated by dividing pfu obtained when 
infected with non-methylated X by pfu obtained when infected with methylated X. 
Phage X dilution buffer consisted of 50 mM Tris-HCl (pH 7.8), 0.2M NaCl, and 
0.4% M gS04.7H20 .
Strains to be assayed were grown to 0.5-1.0 OD600 and 300 p\ of culture was 
added to 100 pi of a phage dilution that would yield countable numbers (30-300) 
of pfu. A dilution of IQ'8 was used for non-methylated X, and dilutions of 10'6, 10'7, 
and 10'8 were used for methylated X. To this phage-cell mixture, 2.5 mis. of 0.8% 
top agar were added and the entire mix poured onto an L-agar plate. Plaques were 
counted after overnight incubation. Methylated X was designated X.BsuRl and non- 
methylated X was designated X.0.
M crBC assay using methylase plasmids. Transformation of E. coli strains 
with a plasmid encoding the M.&mRI methylase provides a highly sensitive assay 
to analyze weakly restricting strains. A 2.0-kb Clal-BamHl fragment was removed 
from pM.&wRIlO and ligated into C/al-ZtawHI-digested pACYC184 and designated 
pM .&«RI20. Plasmid DNA was collected using the Birnboim procedure (9) and 
further purified using the CsCl-ethidium bromide density gradient method (46). Host 
strains to be tested for McrBC activity were transformed (67) with 0.1 pg of either 
pM.ZfrwRIlO or pM.ZB'wRI20. As compared to the negative or non-restricting strain
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DH5o;MCR (pBAB99), strains possessing higher restriction levels displayed lower 
transformation frequencies. Transformation efficiency (number of colony forming 
units [cfu] per 0.1 jug plasmid DNA) was determined by comparison of potentially 
restricting host strains with the McrBC-strain DH5aMCR (pBAB99). Restriction 
was determined by dividing the number of cfu obtained when a given host was 
transformed with non-methylated plasmid by the number of cfu obtained when 
transformed with methylated plasmid.
McrB* assay using methylated X phage. McrB* is defined as restriction 
observed with the expression of the mcrB gene alone and is differentiated from 
restriction requiring mcrBC expression (defined above). A 4.4-kb EcoRl fragment 
from B. subtilis R lysogenized with SPR phage was ligated to AcoRI-digested 
pBR322, and the resulting construct was designated pM.SPRlO. Again, X was used 
to infect DH5aMCR (pM.SPRlO) and the lysate containing phage methylated at 
mCCGG and GGmCC sites was collected. These methylated X phage were designated 
X.SPR. EOP and restriction were calculated as described in the McrBC assay using 
methylated X phage. McrB* activity is observed with the mcrB gene alone and can 
be assayed with DNA modified at the methylation site mCCGG.
McrB* assay using methylase plasmids. This assay was used as a more 
sensitive means of measuring McrB* restriction. A 2.8-kb Clal-Bgll fragment from 
pM.SPRlO was ligated to CM-BawHI-digested pACYC184, and the resulting 
recombinant plasmid was designated pM.SPR20. Either this construct or pM.SPRlO 
were used to transform potentially restricting strains, and restriction levels were
measured by comparing the transformation efficiency to that obtained for the 
m crBC' host DH5ceMCR (pBAB99).
RglB assay. This assay measures a host strain’s ability to restrict non- 
glucosylated T4 phage DNA (T4gr) and was performed as previously described (66). 
EOP was determined by comparing the number of pfu obtained when infecting a 
potentially restricting host with T4gt to the pfu obtained when infecting the McrBC- 
strain DH5aMCR (pBAB99). All phage dilutions were made in LB broth. 
Restriction was calculated for a given strain by dividing pfu obtained due to T4 
infection by pfu obtained due to T4gt infection.
Antisense RNA-producing plasmid constructs. All antisense RNA 
producing constructs were derived from pA R V ll which combines high level 
transcription initiation from the B. subtilis phage SP82 early gene promoter 
Sau3A253 (1) with the RNA-stabilizing properties of the B. thuringiensis cry A  gene 
terminator (79). pA R V ll contains a polylinker site into which small DNA 
fragments containing the proposed ribosomal binding site (RBS) and initial coding 
region for each of the three peptides were inserted in the antisense orientation. This 
results in production of RNA that is stable and in relatively high copy number 
compared to the single chromosomal copy to be targeted. Antisense RNA1 (ASR1) 
was designed to block the RBS for McrBL, ASR2 the RBS for McrBs, and ASR3 the 
RBS for the 38-kDa McrC polypeptide.
pASRl consists of a Sspl-Hindlll fragment (nucleotide 73 - 191) (24) ligated 
into pA R V ll that has been digested with Hindlll and H indi. pASR2 is made by 
ligation of an Sspl fragment (nucleotide 470 - 606) (24) into H indi digested
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pA R V ll. pASR3 was constructed by ligation of an EcoRV  fragment (nucleotide 
1314 - 1518) (24) into H ind i digested pARVl 1. The orientation of each insert was 
confirmed by restriction analysis using insert restriction sites located asymmetrically.
Plate method of lawn formation to assay antisense-containing strains. 
The given strain was grown overnight at 37° C on an L-agar plate which contained 
the appropriate antibiotic. Cells scraped from the agar surface were suspended in 
broth to a density of approximately 2.0 OD600 units. The cell suspensions were used 
to create lawns for McrBC assay using phage X.
SOS induction. The induction of the SOS system was measured with a sulA 
- lacZ gene fusion. The plasmid containing the transcriptional fusion pRGC13 was 
constructed by inserting the lacZ gene (via MudI1734) (4) behind the sulA promoter 
(72). The region with the sulA - lacZ fusion was removed from pRCG13 via a 
BamHl digestion and ligated to ZtamHI-digested pACYC184 and called pBAB33.
To test the response of pBAB33 containing strains to SOS induction, 
mitomycin C was used to induce the SOS response. JM107 (pBAB33) was sampled 
at approximately 0.3 OD600 and 12.5 jul of mitomycin C (final conc. of 0.5 /xg/ml) 
was added to induce the SOS response. Samples were taken 1,2,4, and 6 hours 
later. Parallel samples were taken from an un-induced culture of the same strain. 
From these samples, /3-galactosidase was assayed as previously described (48) and 
an induction curve was produced. Restriction-positive strains containing the 
constructs pBAB33, pBAB33 plus pASR2, or pBAB33 plus pBR322 were grown 
overnight and, from these, 1 ml was used to inoculate flasks containing 50 ml of L 
broth (48) with the appropriate antibiotic added. These flasks were shaken in a 37°
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C shaker-incubator. /3-galactosidase levels in a strain possessing pBAB33 and 
pASR2 were assayed in cultures with an OD600 of approximately 0.5 and 2.25 and 
compared with this induction curve.
Construction of plasmids for overexpression of McrBC peptides. 
Construction of pRAB14d (65), pRAB16 (66), and pRAB17 (67) has been explained 
previously. Another construct used to overproduce the mcrB gene products was 
designated pBAB51. It was constructed by ligating an EcoRl-Nsil fragment of 
pRAB12 (66) into EcoRl-PstI digested pUC18 (83). The construct designated 
pBAB34 was made by removal of the Nsil fragment of pRAB14d (65). This Nsil 
deletion effectively removes the mcrC gene. A 2.75-kb EcoRl-Scal fragment from 
pRAB13 (65, 66) was ligated to EcoRl-Scal digested pACYC184 and designated 
pBAB43. This insert includes mcrB only. A 1.6-kb EcoRl-Pstl fragment from 
pRAB16 (66) was ligated to EcoRl-Pstl digested pBR322 and designated pBAB56. 
This insert includes mcrC only and, as this gene lacks its own promoter, it was 
necessary to provide one in order to see mcrC expression. A 301-bp EcoRl 
fragment possessing an early gene promoter from B. subtilis phage SP82 was ligated 
to £coRI-digested pBAB56 and designated pBAB56a.
Plasmids expressing truncated M crBs. A series of plasmids were 
constructed that contained sequentially greater truncations of the 897-bp mcrBs gene. 
Plasmid pBAB70 was constructed by shortening the mcrBs ORF by 84 nucleotides 
(leaving 813 nucleotides remaining) through digestion of pRAB14d (65) with EcoRV. 
This digestion removed a 1.4-kb EcoRV  fragment and the remaining 5.5-kb fragment
was re-ligated to itself. The presumptive product produced from this construct was 
designated McrBs271.
Plasmid pBAB71 lacks 354 of 897 nucleotides from the mcrBs ORF (leaving 
543 nucleotides remaining). The presumptive product produced from this construct 
was designated McrBs181. A Hindlll deletion was performed on pRABll (68), a 
0.32-kb fragment removed and the remaining 3.55-kb fragment ligated to itself.
Plasmid pBAB74 lacks 702 nucleotides of the mcrBs ORF (leaving 195 
nucleotides remaining). The presumptive product produced from this construct was 
designated McrBs65. A 502-bp Hindlll-BstVl fragment from pRAB14d (65) was 
ligated to Hindlll-Hincll digested pUC19.
The plasmid pASR2 (Materials and Methods, Antisense RNA producing 
plasmid constructs) was digested with BamHl, and the 144-bp BarnHl fragment was 
ligated into BamHl digested pUC19 and designated pBAB75. This insert consists 
of the 134-bp Sspl fragment of mcrB and lacks 792 nucleotides of the mcrBs ORF 
(leaving 105 nucleotides remaining). The presumptive protein product was 
designated McrBs35.
McrBC-DNA UV cross linking analysis. To analyze the interaction between 
the McrBC proteins and DNA, UV photo-cross linking was used to detect protein 
binding to labeled DNA fragments. Cell extracts from strains producing the various 
proteins of mcrBC were tested for DNA binding. To prepare cell extracts, strains 
were grown overnight, pelleted, and re-suspended in a binding buffer that consisted 
of the following: 20 mM HEPES, 2 mM EDTA (pH 8.0), 6 mM Tris-HCl (pH 7.9), 
84 mM KC1, and 5% glycerol. Dithiothreitol (DTT) (1 mM final conc.) and
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phenylmethylsulfonyl floride (PMSF) (50 /xg/ml final concentration) were added to 
the re-suspended pellet. These cells were lysed by sonication using four, ten-second 
pulses with the microtip of an ultrasonic processor (Model W-220, Heat System- 
Ultrasonics, Inc.).
Protein concentration was determined for cell free extracts by using the BIO 
RAD Protein assay based on the Bradford technique (17) according to the 
manufacturer’s instructions. The binding reaction was set up as follows: 10,000 cpm 
DNA probe, 0.5 tag poly(dldC)-poly(dldC), 1 mM GTP, 300 /-cg/ml of bovine serum 
albumin (BSA), and 15 jxg protein from crude extract. Actual binding reaction 
conditions were as follows: 12 mM HEPES (pH 7.9), 1.2 mM EDTA, 3.6 mM Tris- 
HC1 (pH 7.9), 50 mM KC1, and 10% glycerol with a final reaction volume of 15 
to 20 fil. To reach these concentrations, binding buffer may be added to the 
reaction. Each of the binding reactions was mixed into a microcentrifuge tube and 
then added onto a cellophane-covered heating block set at 30° C. After five minutes 
of incubation the binding reactions were irradiated with 254-nm UV light (Model SL 
253 mineral light, Ultra-Violet Products Inc., South Pasadena, CA.) for 15 minutes 
from a distance of 3 cm. These samples were then loaded onto a high ionic strength 
polyacrylamide gel (21) and run at 150 V for approximately 2.5 hours.
Sequencing of target fragments used for McrBC-DNA UV cross linking 
analysis. The DNA target fragments used in McrBC-DNA UV cross linking 
analysis possessed one, two, or three Pvull sites. The DNA fragments possessing 
two and three sites were constructed from ligation of multiple 37-bp fragments. It 
became necessary to sequence these DNA fragments to discover the distance between
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the multiple Pvull sites as this is information relevant to models currently proposed 
for restriction site requirements. Sequencing was kindly performed by Dr. Alan Biel 
using the Circumvent™ kit manufactured by New England Biolabs. Thermal cycle 
sequencing (2) (asymmetric PCR) using plasmid template was performed according 
to manufacturer’s directions.
Target preparation for UV cross linking. A series of DNA fragments 
containing 1, 2, or 3 Pvull methylation sites were prepared. The Pvull methylation 
site was constructed by digesting pUC18 with Pvull followed by ligation to delete 
a 322-bp fragment which included the polylinker cloning sites. The plasmid was 
designated pBAB99. DNA containing this regenerated Pvull site was cut out with 
Haelll to yield a 37-bp blunt ended fragment which was ligated into Smal digested 
pUC18. A plasmid containing one copy of the 37-bp fragment was designated 
pBAB63, while two and three copies of this fragment were present in pBAB63.11 
and pBAB63.1, respectively. The constructs were digested with EcoRl-BamHl to 
remove the entire target insert for end labeling. The Pvull site in the pBAB61 
EcoBl-BamHl fragment was at least 70-bp from either fragment end. The Pvull site 
in the same fragment of pBAB62 was 22-bp from one fragment end.
To place the Pvull methylation site on a longer DNA fragment, the plasmid 
pBAB99 was digested with fo/TJI, and a 223-bp fragment containing the Pvull site 
was ligated into Smal-digested pUC18. The resulting construct was designated 
pBAB62. A second Pvull methylation site was cloned for analysis. Plasmid 
pBAB61 contains the Pvull methylase site from pBR322. The plasmid pBR322 was 
digested with Haelll and Mspl, and the 170-base pair insert containing the Pvull site
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was ligated into AccI-S/wI-digested pUC18. The target fragments of both pBAB61 
and pBAB62 could be removed by EcoRl-BamUl for end labeling.
A host strain containing the Pvull methylase gene was transformed with 
pBAB61, pBAB62, pBAB63.1, or pBAB63.11. All four plasmids were then purified 
by the procedure of Birnboim (9) and further purified by CsCl-ethidium bromide 
density gradient centrifugation (46) procedures. Each of these constructs was shown 
to be methylated by the inability of Pvull to cleave at its sites. Methylated target 
fragments were generated by digestion with EcoRl-BamHl, and DNA fragments 
were end labeled using [o;-32P]dATP (NEN, Dupont) and the Klenow fragment of 
DNA Polymerase I (Gibco, BRL) according to manufacturer’s conditions.
Antibody purification and W estern blotting. Polyclonal antibodies against 
the mcrB gene products were produced in rabbits using purified McrBL and McrBs 
(88). This crude antiserum was a kind gift from Dr. H. Douglas Braymer. The 
polyclonal McrB antibodies were purified using Pharmacia’s Protein G Sepharose 
4 Fast Flow column with Bio Rad’s Econo system. Standard binding (PBS), elution 
(glycine-HCl, pH 2.7), and neutralizing (BBS) buffers were used (21). The flow 
rate for antibody binding was 0.5 ml/min. and for elution was 2.7 ml/min. Eluant 
was collected directly into dialysis tubing, dialyzed against BBS, and then 
concentrated with an Amicon filter system. The resulting concentrate was allowed 
to incubate for 30 minutes at 56° C to inactive complement and stored in 0.02% 
azide at -20° C.
To eliminate background from polyclonal antibodies specific for other E. coli 
proteins (other than McrB), a pretreatment was required. An E. coli mcrBC deletion
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strain was grown to 0.6 OD600 and three, ten ml alloquots were pelleted and 
suspended in 1 % azide PBS for 3 to 4 hours. Antibody was then added to azide- 
killed cells, suspended to a final dilution of 1/100, and allowed to bind at room 
temperature for 30 minutes. Cells were pelleted, the supernatant added to a new cell 
pellet of azide killed cells, and again allowed to bind for 30 minutes. This was 
repeated once more and supernatant was collected. Sufficient cell free extract from 
a McrBC deletion strain was added to the supernatant to a protein concentration of
I mg/ml. Addition of this protein extract yielded a primary antibody final dilution 
of 1/1,200. The secondary antibody dilution was 1/7,500, and the strepavadin 
alkaline phosphatase 1/10,000. The blotting detection kit for rabbit antibodies from 
Amersham was used and all manufacturer’s parameters were used, except the 
previous dilutions listed. The primary antibody was allowed to bind overnight.
Western blots were performed using standard procedures (70). Strains to be 
used in this assay were pelleted and re-suspended in TEN buffer (50 mM :l mM:50 
mM). PMSF (50 /ig/ml final conc.) and DTT (1 mM final conc.) were added to the 
cell suspension. Cells were lysed by sonication (as described previously) and 40 jxg 
protein extract was loaded onto a Bio Rad 4% - 20% Mini-PROTEAN II Ready gel. 
The gel was run at 200V for approximately 1 hour using a Bio Rad Mini-PROTEAN
II cell. Electroblotting was performed using Bio Rad’s Mini Trans-Blot cell at 25 
milliamps for 1 hour.
Digestions with McrBC crude extracts. Cell free extracts were used to 
examine the restriction ability of various strains as well as the necessity of various 
cofactors. This assay was also performed as an in vitro verification that the
restriction positive strains were restricting DNA and that this restriction was 
dependent on site methylation. Three mis. of an overnight culture were pelleted and 
suspended in 400 /il of 50 mM Tris-HCl, 1 mM EOTA and 50 mM NaCl (TEN) and 
PMSF added (final conc. 50 /xg/ml). Cells were lysed using sonication (as described 
previously).
Digestion substrates were pM.2?mRI20 and pNM.ZEwRI20. The plasmid 
pNM.ZJmRI20 was produced by transforming ER1381 (mcrA+, mcrBC*) with 
pM.ifowRKO. Plasmids were purified from colonies produced from this 
transformation and digested with HaeIII as a means to test for any pM.5.«/RI20 that 
had lost their methylation ability. Haelll cleavage was taken as evidence that the 
methylase gene in these constructs was inactive and that these Haelll sites were non- 
methylated. Upon linearization of pNM.ZfrwRI20, and comparison with linearized 
pM.2fruRI20, it was noted that the former appeared slightly larger using agarose gel 
electrophoresis. This was taken as evidence that an insertion had inactivated the 
methylase gene.
Digestions were performed using approximately 0.1 jug substrate DNA, 10-20 
lil crude extract (30-50 jig protein), IX React 2 enzyme buffer and different 
concentrations of GTP or ATP. Digestions were allowed to incubate for one hour 
at 37° C.
RESULTS
Evidence for subunit interaction. Three different gene products are 
produced from the mcrBC region. The mcrB gene produces peptides of 53-kDa 
(McrBL) and 35-kDa (McrBs). The mcrC gene produces a 38-kDa peptide. To 
examine the relationship between subunit abundance and McrBC activity, these 
different gene products were over-expressed using various subclones of the mcrBC 
region (Fig. 1). The recombinant plasmid pRAB17 (67) was used to express McrBs 
while the plasmid pBAB51 expressed McrBL and McrBs. The plasmid pRAB16 
expressed McrC (66), while pRAB14d (65) expressed McrBs and McrC. 
Overproduction of authentic McrBL alone was not possible as McrBs is produced 
from an ORF that is located within the mcrB gene. McrBs is virtually identical to 
McrBL except that it lacks 35 % of McrBL from the N-terminal end (67). This means 
that McrBL was not produced without synthesis of McrBs as well.
The mcrBC+ host, JM107, was transformed with the various subclones and 
changes in restriction levels were measured. Restriction was measured as McrBC, 
McrB*, and Rgl activities using specifically modified substrates. The assays utilized 
5-methylcytosine (m5C)-containing-DNA for measure of McrBC or McrB* restriction 
or 5-hydroxymethylcytosine (lu"5C)-containing T4 DNA for measure of Rgl 
restriction. Phage lambda and plasmids used in the McrBC assay were methylated 
by M.BjmRI and carried a methylation pattern identical to that produced by M.Haelll 
methylase (GGmCC). Substrate DNA used in the McrB* assay was methylated by 
M.SPR and carried the same pattern (GGmCC) plus a pattern identical to that 
produced by M.Mspl (mCCGG). Changes in restriction levels were determined by
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Fig. 1 - Constructs used to overexpress McrB, and McrBs in a M crBC+ background. The mcrB gene products were 
overexpressed in a McrBC+ background using pUC8 as the vector for cloning of the above inserts.
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comparison of restriction by JM107 containing the relevant subclone, to JM107 
(pBAB99) as a positive control and DH5aMCR (pBAB99) as a negative control. 
Plasmid pBAB99 is a pUC18 derivative with the a-complementation region deleted. 
Restriction of non-glucosylated bacteriophage T4gt DNA was compared to that 
observed with wild-type bacteriophage T4 DNA.
Wild-type McrBC restriction observed with JM107 (pBAB99) was 43-fold 
greater than that of the negative control, DH5gMCR (pBAB99). When McrBs was 
overexpressed using JM107 (pRAB17), restriction decreased to 2.8-fold (Table 2). 
This loss of restriction observed when McrBs was overexpressed was also detected 
with the Rgl assay. Wild-type Rgl restriction was eliminated with overexpression 
of McrBs. This was the initial indication that McrBs affects or modulates the activity 
of McrBC restriction in vivo.
To verify that McrBs was being overproduced by pRAB17, a Western blot 
(70) was performed and the relative intensity of band staining compared by 
densitometry (Fig. 2). Although the effect of McrBs overexpression on McrBC 
restriction was examined using JM107, this host strain could not be used for Western 
blotting. Western blot analysis is not sensitive enough to reproducibly detect wild- 
type levels of McrBs. Since it was impossible to compare the levels of McrBs in 
JM107 to the overexpressed levels observed with pRAB17, the levels of McrBs 
produced from two plasmid constructs were compared. To obtain detectable McrBs 
levels, pBAB43 was used to express mcrB (Fig. 3). This plasmid is a derivative of 
the vector pACYC184 with approximately 20 copies/chromosome (20). In 
DH5aMCR (pBAB43, pBAB99), the McrBL/McrBs ratio was 13/1. With the strain
Table 2. The effect of subunit overexpression on McrBC restriction
M crB Restriction Efficiency of Platins 
(EOP)a
Restriction
A.O X.BsuRl
DH5aMCR (pBAB99) 1.0 1.0 1.0
JM107 (pBAB99) 1.3 3.0 x lO'2 43
JM107 (pRAB16) 0.9 3.0 x 101 3.0
JM107 (pRAB17) 1.1 3.9 x 101 2.8
JM107 (pBAB51) 1.2 2.0 x lO'2 60
JM107 (pRAB14d) 1.0 2.0 x 10'2 50
JM107 (pBAB34) 1.0 2.5 x 101 4.0
Efficiency of Plating 
(EOP)a
Restriction'
Rgl Restriction T4 T4 gt
DH5aMCR (pBAB99) 1.0 1.0 1.0
JM107 (pBAB99) 0.6 4.5 x lO6 1.3 x 105
JM107 (pRAB16) 0.4 0.8 0.5
JM107 (pRAB17) 0.7 0.5 1.4
JM107 (pBAB51) 0.7 6.2 x lO'7 1.1 x 106
JM107 (pRAB14d) 0.4 2.5 x 10'6 1.6 x 105
JM107 (pBAB34) 0.7 0.2 3.5
a Efficiency of plating is defined as: titer of the phage on strain x / titer of the
phage on permissive host DH5aMCR (pBAB99). 
b Restriction is defined as: restriction of non-methylated DNA / restriction of
methylated DNA.
c Restriction is defined as: restriction of glucosylated DNA / restriction on non-
glucosylated DNA.
6 o****
Lane 1 2 3 4  5 6 7 8 9  10
f i g  Protein N/A 70 20 30 50 70 20 30 50 70
Fig. 2 - W estern blot analysis fo r overproduction of M crBs. Lane 1 contains protein 
standards; numbers represent molecular mass in kDa. Lane 2 contains extract prepared 
from McrBC" cells. Lanes 3 - 6  contain extract from DH5oMCR (pBAB43, pBAB99). 
Lanes 7-10 contain extract from DH5aMCR (pBAB43, pRAB17). Amounts of extract 
added to each lane is listed. Note that the McrBL band is designated by an arrow 
labeled "A".
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Fig. 3 - Subclones of McrBC region used to express genes individually. Plasmid pBAB43 was constructed with the vector 
pACYC184 and was used in the McrB* assay. Plasmid pBAB56a was constructed using pBR322 and was used for the "restriction 
rescue" assay.
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DH5g;MCR (pBAB43, pRAB17), the ratio changed to 0.8/1. This represents a 16- 
fold increase in McrBs levels while the level of McrBL remains unchanged. It 
should be noted that the ratio of McrBL/McrBs is based on detection with polyclonal 
antibody and can only be used to compare the relative levels of McrBs between 
strains. Since the background levels of McrBL and McrBs are provided by a plasmid 
with a copy number 20-fold greater than the chromosome, determinations of McrBs 
overproduction were underestimated by as much as a factor of 20. Estimations of 
McrBs overproduction place it at 320 times that of the wild-type levels.
When McrBs is overproduced, restriction is diminished. Since 
overproduction of McrBs did not decrease the levels of McrBL, it is unlikely that 
McrBs overproduction results in repression of McrBL. To test if it is the absolute 
levels of McrBs or the altered ratio of McrBs to other components in the restriction 
system, McrBL and McrBs were overproduced with pBAB51. When both McrBL and 
McrBs were overproduced as verified by Western blot using JM107 (pBABS 1), there 
was no loss of restriction (Table 2). In fact, there was a slight but reproducible 
increase in restriction ability. This suggests that overproduction of both mcrB 
products does not disrupt the subunit ratio necessary for the formation of the active 
complex. These results suggest that it is the altered proportions of McrBs to McrBL 
that is inhibitory, that McrBL and McrBs interact and/or that these two proteins 
interact with a common protein, which is likely McrC. Both of these hypotheses 
were tested.
M crBL-McrBs interaction. Using the McrB* restriction assay, additional 
evidence was sought that McrBL and McrBs interact. Full restriction of X.SPR as
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defined by the positive control JM107 (pBAB99) was 61 fold. The mcr deletion 
strain DH5aMCR was transformed with pBAB43, which encodes the mcrB gene, 
and when infected with X.SPR, restriction was measured at 45-fold greater than the 
negative control DH5aMCR (pBAB99). The strain DH5aMCR (pBAB43, pRAB17) 
displayed 25.6-fold restriction (Table 3). The presence of pRAB17 caused the 
overproduction of McrBs and suggested that McrBs interacted with McrBL and 
inhibited the McrB* activity.
As stated previously, pRAB17 caused a 16-fold increase in McrBs levels in 
this strain. While not dramatic, the loss of restriction from 45 fold to 26 fold is 
repeatable. It is thought that this restriction loss is not greater because the mcrB to 
mcrBs ratio is approximately 1:10, rather than 1:200 as would be the case if a 
chromosomally encoded mcrB+C~ host was available. These ratios were calculated 
using the copy numbers of the plasmid vectors used.
M crBs-M crC interaction. Overexpression of McrC was achieved using 
JM107 (pRAB16). This resulted in a change from 43-fold McrBC restriction, as 
seen with JM107 (pBAB99) to 3-fold McrBC restriction (Table 2). Overexpression 
with pRAB16 also caused complete elimination of Rgl restriction. This suggests that 
excess McrC disrupts active complex formation, or represses the synthesis of McrB. 
Western blot analysis detected no effect on synthesis of McrBL or McrBs when McrC 
was overexpressed (data not shown). The possibility that McrC overexpression 
affected active complex formation was tested.
Overexpression of either McrBs or McrC dramatically reduced McrBC and 
Rgl restriction. To test whether these two proteins interact, the host JM107
Table 3. The effect of overexpression of truncated mcrBs genes
on McrB* restriction
Efficiency o f Plating Restriction1* Efficiency of Plating Restriction* 
(EOP)a (EOP)a
M X.SPR X.RshRI
DH5aMCR (pBAB99) 1.0 1.0 1.0 1.0 1.0 1.0
JM107 (pBAB99) 1.1 1.8xl0'2 61 0.9 0.02 45
DH5aMCR (pBAB43, 
pBAB99) 0.9 2.0xl0'2 45 0.8 1.0 0.8
DH5aMCR (pBAB43, 
pRAB17) 1.1 4.3xl0‘2 26 0.9 1.0 0.9
DH5aMCR (pBAB43, 
pBAB70) 0.9 2.2xl0'2 41 1.0 0.8 1.3
DH5aMCR (pBAB43, 
pBAB71) 1.2 2.5xl0'2 46 1.2 1.2 1.0
DH5aMCR (pBAB43, 
pBAB74) 0.7 7.0xl0'3 100 0.9 0.7 1.3
DH5aMCR (pBAB43, 
pBAB75) 0.4 1.3xl0'3 320 0.25 0.44 0.6
a Efficiency of plating is defined as: titer of the phage on strain x / titer of the
phage on permissive host DH5aMCR (pBAB99). 
b Restriction is defined as: restriction of non-methylated DNA / restriction of
methylated DNA.
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(mcrBC1") was transformed with pRABl4d (65) which expresses McrBs and McrC 
as previously verified by maxi-cell analysis (65). When both McrBs and McrC 
proteins were overexpressed together, no loss of restriction was seen. Restriction 
was at or slightly above that of the positive control, JM107 (pBAB99) (Table 2). 
We term this "restriction rescue," meaning the loss of restriction caused by 
overproduction of McrBs or McrC in JM107 is restored when both are produced 
together. It was previously shown that pRAB14d does not impart McrBC restriction 
of mcrBC" hosts (65). To confirm that both peptides expressed from pRAB14d are 
required for restored activity, pBAB34 was created from pRAB14d (Fig. 4) by 
deleting the McrC coding region. JM107 was transformed with pBAB34, and 
McrBC and Rgl assays were performed (Table 2). Full restriction was represented 
by JM107 (pBAB99) and was seen as Rgl restriction of 1.3 x 105 fold and McrBC 
restriction of 43 fold above restriction levels of the negative control DH5aMCR 
(pBAB99) (Table 2). With pBAB34 (Table 3), there is virtually no restriction 
observed as would be expected with an over-producer of McrBs in a wild-type host. 
An Rgl restriction level of 3.5 fold and an McrBC restriction level of 4 fold are 
comparable to those levels seen with McrBs overproduction in JM107 (pRAB17) and 
with the negative control DH5aMCR (pBAB99).
To verify these findings, the wild-type strain (JM107) was transformed with 
pBAB56a (Fig. 3). This resulted in overexpression of McrC and caused McrBC 
restriction to drop from 90 fold to 8 fold. When JM107 (pBAB56a) was 
transformed with pRAB17, which encoded overproduction of McrBs, "restriction 
rescue" was seen to occur, and full restriction was once again seen. At 128-fold,
H incII H incII
B g ll l SspI EcoRY N sil
EcoRV H indll I N sil H incII
! H incII SspI EcoRV S tu I
I 1 H incII
i i i
1 SspI
i i i i i
Seal
i i
EcoRV
i l l  ii , . | , | . i , ,
EcoRI
mcrB mcrC
PRAB16
pRAB14d
pBAB34
Fig. 4 - Constructs used to test McrBs-McrC interaction. The open boxes represent the fragment of DNA used to construct the 
listed plasmids. All constructs were made using the vector pUC8.
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restriction was observed at, or slightly above, that observed with the positive 
control, JM107 (pBAB99).
While overexpression of either McrC or McrBs leads to loss of restriction, 
simultaneous overexpression of these proteins permits full restriction by 
chromosomally encoded McrBC. Alone or together McrC and McrBs cannot impart 
restriction to DH5aMCR (mcrB~C~). This suggests that McrC and McrBs interact 
or complex together to prevent them from disrupting normal McrBC restriction.
Use of antisense RNA to affect McrBC restriction. To decrease the levels 
of the individual proteins produced from the mcrBC operon, antisense RNAs were 
made using pA R V ll as the vector (Fig. 5). These antisense RNAs were made in 
such a way that they blocked the translational initiation sites of McrBL, McrBs, and 
McrC (Fig. 6). It should be noted that all changes in EOP levels are made in 
comparison to the restriction negative control DH5orMCR (pBAB99) and changes in 
restriction are compared to full restriction as expressed by JM107 (pARVll).
The mcrBC* host JM107 was transformed with the construct designated 
pASRl to inhibit synthesis of McrBL. With pASRl present, McrBC restriction 
drops from 30 fold to 4.6 fold and Rgl restriction drops from 7.0 x 10s fold to 50 
fold (Table 4). This result was entirely expected as McrBL is the restriction subunit 
and necessary for restriction of all targets (24, 65, 66). It should be noted that with 
pASRl present, JM107 displayed healthy growth, and cells were observed to be 
normal when viewed with a phase-contrast microscope.
Inhibition of McrC synthesis in JM107 using the construct designated pASR3 
resulted in a decrease in McrBC restriction from 30 fold to 4.5 fold and in Rgl
Smal 
r EcoRIEcoRI
SFo2 Prom oter term inato
pARVll
3282 bps
Fig. 5 - Antisense RNA vector. This vector combines high level transcription initiation from the B. subtilis phage SP82 early gene 
promoter Sau3 A253 with the RNA stabilizing properties of the B. thuringiensis cryA gene terminator.
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Fig. 6 - Antisense RNA producing constructs. Each of the above DNA fragments was cloned in antisense orientation using the 
vector pARVl 1. The resulting RNA produced targeted the ribosome binding sites of the three McrBC protein products.
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Table 4. Use of antisense RNA to facilitate underexpression
McrB Restriction Efficiency of Plating 
(EOP)a
Restriction15
M X.BsuRl
DH5aMCR (pBAB99) 1.0 1.0 1.0
JM107 (pARVll) 1.5 5 x lO'2 30
JM107 (pASRl) 1.3 0.3 4.5
JM107 (pASR2) 1.6 0.3 5.9*
JM107 (pASR3) 1.3 0.3 4.5
Efficiency of Plating 
tEOP)a
Restriction'
Rgl Restriction T4 T4 gt
DH5ceMCR (pBAB99) 1.0 1.0 1.0
JM107 (pARVll) 1.2 1.7 x 10'6 7 x 10s
JM107 (pASRl) 1.5 3.0 x 10r2 50
JM107 (pASR2) 1.3 3.0 x lO'2 43*
JM107 (pASR3) 1.1 0.6 2
a Efficiency of plating is defined as: titer of the phage on strain x / titer of the
phage on permissive host DH5aMCR (pBAB99). 
b Restriction is defined as: restriction of non-methylated DNA / restriction of
methylated DNA.
c Restriction is defined as: restriction of glucosylated DNA / restriction on non-
glucosylated DNA.
* Although observed restriction levels with JM107 (ASR2) were variable, this
restriction level was repeatable using the "plate scraping" method.
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restriction from 7 x 105 fold to 2 fold (Table 4). Since McrC in conjunction with 
McrBL is known to be necessary for restriction of most methylated DNA templets 
(24, 40, 51, 65) and lun5C containing DNA (58, 61), lowered amounts of McrC 
produced expected results of dramatically reduced McrBC and Rgl restriction. It 
follows that lowered expression of McrC should not affect McrB* restriction as this 
restriction ability can occur with rncrB alone. This in fact proved to be true. In a 
side-by-side assay, ASR3 was shown to reduce McrBC restriction while not altering 
McrB* restriction. JM107 (pASR3) was also seen to possess normal growth and 
appearance when viewed with a phase-contrast microscope.
Plasmid pASR2 was constructed to inhibit synthesis of McrBs. Presence of 
this construct in JM107 had two immediately evident effects: (1) a slow growing cell 
that lysed upon serial transfer in broth medium, and (2) variable results of the 
McrBC and Rgl assays. In early attempts to assay JM107 (pASR2), this construct 
slightly increased restriction, 2 to 5 fold. These results were not readily repeatable 
as cells quickly lysed when growing in the incubator shaker. A method was devised 
to produce bacterial lawns with cells grown on solid media where they were most 
stable. These cells were infected with bacteriophage T4 strains (Rgl assay) or 
bacteriophage \v ir  lysates prepared for the McrBC assay. Under these conditions, 
ASR2 lowered McrBC restriction from 30 fold to 6 fold, and Rgl restriction from 
7 x 10s fold to 43 fold. These results again suggested that McrBs had some 
significant role in the McrBC restriction system and even in cell stability. When 
viewed with a phase contrast microscope, JM107 (pASR2) cells appeared as non-
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septated, filamentous, and pleomorphic. These growth abnormalities are consistent 
with SOS induction.
Western blotting (70) and densitometry were used to verify that ASR2 had 
caused underproduction of McrBs only (Fig. 7). The antisense RNA experiment 
utilized JM107 (pASR2), but this strain could not be used for Western blotting as 
this assay is not sensitive enough to detect chromosomally expressed levels of 
McrBs. To obtain levels of McrBs that were measurable, pBAB43 was used to 
express mcrB in the mcrBC deletion strain DHSceMCR. This construct utilizes 
pACYC184, which has a copy number of 20 plasmids per chromosome. In 
DH5aMCR (pBAB43, pBAB99), the McrBL/McrBs ratio was seen to be 
approximately 4/1. In DH5aMCR (pBAB43, pASR2), the ratio changes to 11/1. 
This represents an almost 3-fold drop in the amount of McrBs in the presence of 
ASR2 while McrBL levels remain unchanged. While this 3-fold drop in McrBs 
demonstrates the ability of ASR2 to inhibit synthesis of this protein, it is a gross 
underestimate of what would be expected from a chromosomally encoded gene. The 
levels of McrBs in JM107 (pASR2) could be as much as 20 fold lower than that 
determined for DH5aMCR (pBAB43, pASR2).
It was hypothesized that the introduction of ASR2 actually increased 
restriction, but this increase was so dramatic that chromosomal damage occurred. 
This would trigger the SOS repair system and error prone DNA repair. The ability 
of pASR2 to induce SOS was examined.
It should be noted that McrBL/McrBs ratios stated in this study were only 
relevant to a particular Western blot. These blots were performed to report a change
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Fig. 7 - W estern blot analysis of M crBs underproduction caused by ASR2. Lanes 
2 - 4  contain extract from DH5aMCR (pBAB43, ASR2). Lanes 6 - 8  contain extract 
from DH5aMCR (pBAB43, pA R V ll). Lane 8 contains 70 fig from DH5aMCR 
(pBAB43, pBAB99), and Lane 9 contains extract from DH5aMCR (pBAB99). Extract 
amounts are listed as /xg protein. The arrow labeled "A" marks the position of the 
McrBs product band. Molecular weight markers in Lanes 1 and 10 are designated in 
kDa.
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in this ratio only and these numbers should not be taken as relevant to the actual 
McrBL/McrBs ratio found in the cell. Ratios varied from blot to blot as the same 
polyclonal antibody alliquot was used repeatedly. McrBL and McrBs share a 
common region and antibodies against this shared region had their numbers 
exhausted before antibodies specific for the unique region found on McrB, . Because 
of this, early uses of a given antibody dilution yielded a McrBL/McrBs ratio closer 
to one than later uses of the same dilution. After repeated antibody uses, McrBs 
appeared in lower amounts relative to McrBL simply because antibody specific for 
the unique region of McrBL was removed from the polyclonal antibody population 
more slowly.
SOS induction as m easured by /J-galactosidase activity. To test the 
hypothesis that the slow growing, filamentous cells observed when JM107 was 
transformed with pASR2 were due to the SOS response, an SOS inducible reporter 
plasmid was constructed with a sulA-lacZ fusion. This plasmid, pBAB33, places j3- 
galactosidase synthesis under the control of the LexA repressible sulA promoter. To 
test the ability of pBAB33 to respond to SOS induction by DNA damage, E. coli 
strain JM107 (pBAB33) was grown in two separate flasks. Mitomycin C at a final 
concentration of 0.5 fxg/ml was added to one flask to induce SOS while the other 
flask served as a control. Both cultures were sampled upon time of induction and 
at 1, 2, 4, and 6 hours post induction. Based on the 0-galactosidase specific activity 
determined with these samples, mitomycin C addition resulted in approximately 2- 
fold increase in expression of sulA-lacZ. The non-induced sample starts at 63 Miller 
units and levels off at 119 units. The SOS induced sample displayed a beginning
reading of 55 Miller units and a final reading of 203 Miller units. Based on this 
control, a two-fold increase in jS-galactosidase activity in pBAB33-containing strains 
would be consistent with SOS induction.
When JM107 (pBAB33) was transformed with pASR2, SOS induction was 
observed. Initial samples taken had an OD600 of 0.55 and a /3-galactosidase specific 
activity of 106 Miller units. This level of /3-galactosidase was twice that of untreated 
JM107 (pBAB33) at a similar optical density. With an OD600 reading of 2.23, the 
/3-galactosidase specific activity was 198 Miller units, which corresponds with 
mitomycin-induced JM107(pBAB33) at comparable optical density. For the control 
JM107 (pBAB33, pBR322) at an OD600 of 2.19, /?-galactosidase specific activity 
was measured at 64 Miller units. Since the antisense RNA produced from pASR2 
specifically targeted McrBs synthesis, the SOS response appears related to the 
underproduction of this protein. This effect was only observed in cells with a 
functional mcrBC operon. This suggests that DNA damage results from McrBC 
restriction system when adequate levels of McrBs are not present.
Altered M crBs proteins. To explore the possible interactions between 
McrBs and the two subunits essential for McrBC restriction, McrBL and McrC, a 
series of plasmids that expressed altered McrBs proteins were made. The altered 
McrBs proteins were analyzed with respect to three different parameters: (1) effect 
on McrBC restriction, (2) ability to interact with the McrC protein using the 
"restriction rescue" assay, and (3) ability to interact with McrBL and effect McrB* 
restriction.
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(1) A series of plasmid constructs was made that encode McrBs proteins 
with sequentially greater truncations at the C-terminal end (Fig. 8). When 
overexpressed in JM107, each of these truncated mcrBs genes, encodes a fraction of 
the full McrBs protein (Table 5). Each plasmid construct was tested for its effect 
on McrBC restriction using bacteriophage X modified by the BsuRl methylase. As 
demonstrated above, when the full length mcrBs gene is overexpressed in JM107, 
McrBC restriction is significantly inhibited. Specifically, full restriction levels 
represented by JM107 (pBAB99) are 60 fold above the negative control, while 
overproduction of McrBs in JM107 (pRAB17) decreases restriction to only 2.6 fold 
above the control.
When each of the truncated McrBs proteins was tested, it was observed that 
as the length of the C-terminal truncation increased, the ability of the McrBs protein 
to inhibit the McrBC restriction decreased. When the last 81 nucleotides of the 
mcrBs gene were deleted (i.e. representing 27 of the 298 amino acids in McrBs) as 
in the plasmid construct pBAB70, restriction increased slightly to 7.7 fold above the 
negative control. A second truncated McrBs protein produced from pBAB71 
contains 181 out of the 298 amino acids in the full length protein. When 
overexpressed in JM107 restriction was 52 fold, essentially the same as observed 
with no McrBs overexpression. This truncation appeared to have eliminated the 
ability of the McrBs protein to inhibit McrBC restriction.
More extensive truncations of the mcrBs gene produced some interesting 
findings. The construct designated JM107 (pBAB74) displayed 120-fold restriction. 
This level was significantly higher than the positive control JM107 (pBAB99) and
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Fig. 8 - Plasmids expressing truncated mcrBs genes. These constructs allow production of truncated McrBs proteins. The open 
boxes represent the DNA fragment cloned into a pUC vector to make the listed construct.
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Table 5. Predicted length of products from  truncated mcrBs genes
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Plasmid Product Name3 Total codons in Product
pRAB17 McrBs 298
pBAB70 McrBs271 317
pBAB71 McrBs181 224
pBAB74 McrBs65 67
pBAB75 McrBs35 53
a Presumptive product names are based on the number of McrBs amino acids 
remaining out of 298.
was termed "hyper-restriction". This elevated restriction is caused by McrBs65, 
which consists of 65 of 298 amino acids of McrBs. While overexpression of this 
truncated McrBs no longer inhibits McrBC activity, it can still interact with the 
complex as evidenced by the hyper-restriction. The construct JM107 (pBAB75) 
contained the smallest segment of mcrBs, 105 out of 897-bp, with the predicted 
peptide, McrBs35, containing only 35 amino acids from McrBs. McrBC restriction 
was 220 fold greater than the negative control (Table 6). This suggested that 
McrBs35 maintains the binding ability of McrBs without the regulatory ability. The 
elevated levels of McrBC restriction may be due to McrBs35 competing with 
endogenous McrBs that is able to inhibit McrBC restriction. None of these plasmids 
alone were seen to confer any restriction ability to the M crB C  host DH5aMCR 
(data not shown). It should be noted that cultures of strains that exhibited hyper­
restriction, JM107 (pBAB74) and JM107 (pBAB75), displayed slightly slower 
generation times and greater numbers of filamentous cells than the untransformed 
host.
(2) The overexpression of mcrC in JM107 resulted in a loss of restriction. 
The overproduction of McrBs in concert with McrC allowed "restriction rescue" or 
recovery of full restriction (Table 7). Full restriction was established by JM107 
(pBAB99) at 90 fold greater than the negative control. When transformed with 
pBAB56a, which encodes mcrC, restriction dropped to 7.7 fold. When JM107 
(pBAB56a) was transformed with pRAB17, which encodes mcrBs, restriction was 
rescued and 130-fold restriction was seen. The series of plasmids encoding 
truncated mcrBs genes was then examined to identify regions of McrBs that interact
Table 6. The effect of overexpression of truncated mcrBs genes
on McrBC restriction
Efficiency of Plating Restriction1’
(EOP)a
X.BsuRl
DH5ceMCR (pBAB99) 1.0 1.0 1.0
JM107 (pBAB99) 1.2 2.0 x 10’1 60
JM107 (pRAB17) 1.0 3.9 x 101 2.6
JM107 (pBAB70) 1.0 1.3 x 101 7.7
JM107 (pBAB71) 7.8 x lO'1 1.5 x lO'2 52
JM107 (pBAB74) 1.1 9.0 x lO'3 120
JM107 (pBAB75) 1.2 5.5 x 10'3 220
a Efficiency of plating is defined as: titer of the phage on strain x / titer of the
phage on permissive host DH5aMCR (pBAB99). 
b Restriction is defined as: restriction of non-methylated DNA / restriction of
methylated DNA.
Table 7. The study of truncated mcrBs genes using the restriction rescue assay
Efficiency of Plating Restrictionb
(EOP)a
DH5aMCR (pBAB99) 1.0
JM107 (pBAB99) 0.9
JM107 (pBAB56a, 
pBAB99) 1.0
JM107 (pBAB56a, 
pRAB17) 0.9
JM107 (pBAB56a, 
pBAB70) 1.0
JM107 (pBAB56a, 
pBAB71) 1.0
JM107 (pBAB56a, 
pBAB74) 1.0
JM107 (pBAB56a, 
pBAB75) 1.1
X.BsuRl
1.0 1.0
1.0 x lO '2 90
1.3 x lO'1 7.7
7.0 x 103 130
9.0 x lO '3 110
7.0 x 10'3 140
8.0 x lO'2 13
7.0 x 10'2 15
a Efficiency of plating is defined as: titer of the phage on strain x / titer of the
phage on permissive host DH5aMCR (pBAB99). 
b Restriction is defined as: restriction of non-methylated DNA / restriction of
methylated DNA.
with McrC. JM107 (pBAB56a) transformed with either pBAB70 or pBAB71 
exhibited restriction rescue with restriction 110 and 140 fold above the negative 
control, respectively. The restriction rescue effect observed with McrBs was still 
evident with truncated McrBs proteins lacking 28 amino acids, as in McrBs271, and 
118 amino acids, as in McrBs181. This suggested that the region of McrBs that 
interacts with McrC was located, at least in part, within the N-terminal half of 
McrBs.
Plasmids containing more extensive truncations of mcrBs, pBAB74 or 
pBAB75 were unable to rescue restriction loss in JM107 (pBAB56a) and restriction 
was measured as 13 fold and 15 fold, respectively (Table 7). One interpretation of 
these data is that the N-terminal half of McrBs is required for interactions with McrC 
as defined by the restriction rescue assay. The C-terminal 118 amino acids do not 
appear necessary for interactions with McrC based on the truncated McrBs expressed 
by pBAB71.
(3) The McrB* restriction assay was used to explore the interaction 
between McrBL and McrBs. In addition, the assay was used to examine the 
phenomenon of hyper-restriction observed with certain truncated forms of McrBs. 
As stated earlier, overproduction of McrBs in DH5aMCR (pBAB43) caused 
decreased McrB* restriction and suggested McrBL-McrBs interaction.
Starting with DH5aMCR (pBAB43) to express the McrBL protein, this strain 
was transformed with either pBAB70 to provide McrBs271 or pBAB71 to provide 
McrBs181. In the McrB* assay, the levels of restriction were equivalent to those 
observed with DH5oMCR (pBAB43, pBAB99) which provides McrB, and McrBs
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in equivalent amounts (i.e. no excess McrBs is present). This suggested that 
McrBs271 and McrBs181 had lost the ability to inhibit McrBL in the McrB* assay. 
It was believed that McrBs271 and McrBs181 could interact with McrBL, but had lost 
their ability to "down regulate" based on results obtained with plasmids containing 
more extensive deletions of mcrBs. DH5aMCR (pBAB43, pBAB74), which 
expressed McrBs65, and DH5aMCR (pBAB43, pBAB75), which expressed McrBs35 
exhibited restriction 100 fold and 320 fold above the negative control, respectively. 
Presence of this hyper-restriction indicated that the peptides could still interact with 
McrBL and enhance restriction possibly by out competing endogenous McrBs.
It should be noted that DH5aMCR (pBAB43, pBAB75) displayed an 
increased level of restriction of the non-methylated X.O (Table 3). Although these 
are not high levels of restriction, they were repeatable and represented either a loss 
of specificity or magnification of a normally low level ability to cleave DNA lacking 
the appropriate methylation pattern. When the truncated McrBs series was tested 
with X.BsuRl in DH5a;MCR (pBAB43), none of the strains exhibited altered 
restriction (Table 3). The phage X.fowRI is not the substrate for McrB* activity of 
DH5o;MCR (pBAB43). This suggests that hyper-restriction is a sequence dependent 
enhancement of the McrBC restriction system.
DH5aMCR (pBAB43,pBAB75) displayed an EOP of 0.44 with X.BsuRl. 
This phage possesses a methylation pattern that should not be restricted by a host 
possessing mcrB without mcrC, yet this seemed to exhibit some restriction. Upon 
further examination, it was noticed that X.O is also slightly restricted by this host 
(Table 3). This suggests that this weak restriction is independent of the traditional
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McrB* restriction recognition sites. It should be noted that DHSceMCR (pBAB43, 
pBAB74) displayed a slower than normal growth rate and, when viewed under 
phase-contrast microscope, a higher than normal amount of filamentous, non-septated 
cells. This was interpreted as evidence of DNA damage and the SOS response. 
DH5oMCR (pBAB43, pBAB75) was seen to possess exceptionally slow growth. 
After 3 days of growth in a 37 °C shaker-incubator, these cells were viewed using 
a phase-contrast microscope. While cell shapes were pleomorphic, there was a 
conspicuous absence of filamentous cells. This may simply have been due to the 
exceptionally slow growth of these cells. Pleomorphic cell morphology, slow 
growth, and high levels of restriction of even non-methylated (i.e., X.O) DNA are 
consistent with excessively high or nonspecific McrBC restriction activity.
Restriction results obtained using methylated X were verified routinely using 
the methylase plasmid assay method (data not shown). This method consistently 
verified results (e.g., the documentation of hyper-restriction), but due to its extreme 
sensitivity, it was often difficult to obtain countable plates.
M crBC restriction in vitro. In vitro restriction of DNA using crude cell-free 
extracts was performed to verify that McrBC+ strains were digesting DNA and that 
this restriction was dependent on methylation of specific sites. The necessity of GTP 
and subunit requirements was also examined. Agarose gel analysis showed that the 
methylated plasmid pM.Bj«RI20 was degraded by extracts from McrBC+ strains, 
while the non-methylated plasmid pNM .&«Rl20 was not (Fig. 9). This analysis 
demonstrated that GTP or ATP was necessary for digestion (Fig. 9). Without either,
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DNA NM M NM  M NM M NM M NM M
ATP or GTP   ~ -  -  GTP GTP ATP ATP
Fig. 9 - Digestion of pM.2?swRI20 and pNM.RsuRKO using crude extracts. In the
row labeled "DNA", NM designates pNM.&»RI20 and M designates pM.fe«RI20. 
Lanes 1 - 6  contain no ATP or GTP. ATP or GTP was added to 0.3 mM where 
indicated. Lanes 1 and 2 contain linearized plasmid while lanes 3 and 4 contain uncut 
plasmid. Lanes 5 - 8 contain approximately 50 /xg McrBC+ crude extract. Note 
digestion of the band A in Lanes 8 and 10.
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no digestion occurs. When GTP or ATP are added at 0.3 mM concentration, they 
seem to allow digestion equally well (Fig. 9, Lanes 8 and 10).
Since digestions used crude cell extracts, once cleaved, the DNA ends were 
exposed to non-specific exonuclease activity for the reaction time. If no DNA was 
seen in a given lane, it was assumed that McrBC had quickly cleaved all possible 
sites on the DNA and allowed degradation by exonucleases into small molecules of 
random length.
The GTP concentration of 0.6 mM allowed more digestion than did 0.3 mM. 
This finding was used to test the stability of McrBC under-reaction conditions. At 
the start of digestion 0.3 mM GTP was added and then an additional 0.3 mM GTP 
was added after 0.5 hours. This sample exhibited no digestion than a sample where 
only 0.3 mM GTP was added and the digestion allowed to proceed for one hour. 
This result suggested that McrBC is short lived or labile since no further digestion 
occurred in this reaction after 0.5 hours even though additional GTP was provided 
(results not shown).
Crude extracts made from a mcrBC+ host also digested T4gt DNA, which 
possesses hydroxymethylcytosine. This was also readily accomplished using extract 
complementation where mcrB+ extracts were insufficient to digest T4gr while they 
could be complemented by mcrC+ extracts to exhibit significant digestion (Table 8). 
Extract complementation was not seen to exhibit significant digestion of 
pM.ZtowRI20. These results suggest that restriction of DNA containing 5- 
hydroxymethylcytosine (T4gr) is significantly more efficient than restriction of DNA 
containing 5-methylcytosine (pM.fi«/RI20). This conclusion agrees with results seen
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Table 8. In vitro cleavage of pM.lfo«RI20 and T4 et DNA using 
extracts made from mutants of the McrBC system
DNAa Extract15 Restr
1 NM +  M B+ _
2 NM +  M B+, C + -
3 T4 B+, C+ -
4 T4 gt B+ -
5 T4 gt B+, C+ +
6 NM, M p l l -
7 NM, M p l l , C + -
8 T4 p l l , C + -
9 T4 gt p l l -
10 T4 gt p l l , C + +
11 NM, M pl2 -
12 NM, M P 12, C+ +
13 T4 pl2 , C + -
14 T4 gt pl2 +
15 T4 gt pl2 , C+ +
a This lane represents DNA used in this assay. NM represents pNM.fl.v//RI20; 
M represents pM.BsnRI20, and in each case pNM.BswRI20 added as a control 
was not digested; T4 represents wild-type T4 DNA; and T4 gt represents non­
glycosylated T4 DNA. 
b Approximately 40 jwg of each cell free extract listed was used. Represented are:
B+ which signifies extract derived from a McrB+ host; C+ which represents 
extract derived from a M crC+ host; p i 1 which represents extract prepared from 
hosts containing pR A B ll, which produces truncated McrB, and McrBs; p l2  
which represents extract made from a host containing pRAB12, which produces 
McrBL, McrBs, and truncated McrC. 
c The minus (-) symbol represents no cleavage, and the plus (+ ) symbol
represents cleavage of pM.ZfawRI20 or phage T4 gt DNA.
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with the in vivo McrBC and Rgl restriction assays. This may be due to the range 
of different modified sequences present in T4gt DNA.
The plasmid pRA Bll (68) produces truncated McrBL and McrBs. Extracts 
produced from a host possessing pRA Bll were not able to digest TAgt DNA. But 
when extract prepared using a pRAB16 (McrC)-possessing host was added to the 
pR A B ll extract, significant digestion occurred (Table 8). This suggests that 
truncated McrBL and McrBs can be complemented by McrC to yield restriction of 
DNA possessing hydroxymethylcytosine. This agrees with the "restriction rescue" 
assay in which pBAB71, a plasmid that produces the same truncated McrBs as 
pR A B ll, was able to bind to McrC.
Extract produced from a host possessing pRAB12 (65) was used for in vitro 
digestions also. Plasmid pRAB12 produces both mcrB gene products and a truncated 
McrC peptide lacking one-third of the C-terminal end. Cleavage of neither 
pNM.fo«RI20 or the methylated pM.ZfvwRI20 occurred using this extract alone. 
However, extract containing authentic McrC did complement the extracts made from 
a pRAB12 containing host. The plasmid pM.fiy«RI20 exhibited cleavage, while 
pNM.&wRI20 did not. These results indicate that the non-methylated plasmid was 
not cleaved by any extract combinations, while the methylated plasmid was cleaved 
when authentic McrBL, McrBs, and McrC were produced by certain vectors. This 
suggests that truncated McrC is insufficient to function as the specificity subunit 
when the target DNA contains m5C. Extract from pRAB12 containing host was 
sufficient to cause cleavage of T4gr suggesting even though McrC has been truncated
it can still function as a specificity subunit well enough to identify TAgt DNA as a 
McrBC target.
In vitro restriction digestions were performed using plasmids containing one 
or two sites methylated by M .Pvull as digestion substrates (Fig. 10). The plasmids 
pBAB99, pBR322, and pBR322 with an £’co0109I deletion each contain one Pvull 
site, while pUC18 contains two Pvull sites separated by 326-bp. All plasmid 
substrates were seen to undergo cleavage (Fig. 10, Lanes 2, 4, 6, and 8). In 
carefully controlled experiments, the linear DNA band generated from a once cut 
plasmid is clearly visible. Not all methylated Pvull sites cleaved equally. The 
methylase plasmid pM .Pvull was present in each plasmid preparation seen in Fig. 
10 and contains two Pvull sites. Limited digestion of pM.PvuII was observed 
relative to the target plasmids (Fig. 10). In a competition digestion study, two 
methylated target plasmids were digested in the same reaction. The relative 
digestion of each target was quantified and compared to all combinations of target 
plasmids. In terms of efficiency of digestion the relative order was: 
pBR322=pBR322 with an EcoO 1091 deletion > pBAB99 > pUC18 > pM.PvuII20 
sites. This site preference was also observed in Fig. 10. In Fig. 10, when the 
pBR322 derived methylated Pvull sites were present, these sites out-competed 
pM.PvuII20 sites for the McrBC endonuclease. Linearized pM.PvuII20 bands were 
present in reactions with the methylated Pvull sites of pUC18 and pBAB99. The site 
from pBR322 and the hybrid Pvull site created in pBAB99 were chosen as targets 
for additional studies. The successful cleavage of these DNA substrates led to their
Lane 1 2 3 4 5 6 7 8
Fig. 10 - In vitro digestion of plasmids containing methylated Pvull sites. Samples 
in Lanes 1, 3, 5, and 7 were treated with extract from McrBC" cells, while samples 
in Lanes 2, 4, 5, and 8 were treated with extract from McrBC+ cells. Lanes 1 and 2 
contain pBAB99. Lanes 3 and 4 contain pUC18. Lanes 5 and 6 contain pBR322, and 
Lanes 7 and 8 contain pBR322 with the £a?0109I deletion. The arrows mark the 
location of linear forms of the plasmids. In Lane 6, the two arrows mark linear forms 
of the dimer and monomer. Each lane also contains the plasmid pM.PvwII20 which 
was used to methylate the plasmids in vivo. The arrow marked "A" is chromosomal 
DNA; "B" is thepM.PvwII20 dimer; and "C" is the pM.PvwII20 monomer. The dashes 
(-) are linearized pM.Pv«II20.
use in the construction of target substrates used in the McrBC-DNA UV cross 
linking assay.
Gel retardation and UV-cross linking assays. To examine the interaction 
between the McrBC restriction enzyme complex and its DNA substrate, gel 
retardation was chosen to separate unbound target DNA from DNA complexed to 
the protein complex. Since the enzyme preparation was to be crude protein 
preparations from E. coli strains, it was essential to use defined target DNA 
fragments. Based on initial experiments with in vitro DNA cleavage with McrBC 
extracts, two Pvull sites were chosen that could be specifically methylated by 
M.PvwII encoded by the plasmid pM.Pv«II20. One site was the Pvull site from 
pBR322 and the other was the hybrid site created upon deletion of the a- 
complementation region of pUC18 using flanking Pvull sites (i.e. the single Pvull 
site found in pBAB99). In addition to testing each site as a single site, the hybrid 
site present in pBAB99 was subcloned as a 37-bp DNA fragment with three copies 
in tandem and with two copies in inverted orientation (Figs. 11, 12). Nucleotide 
sequencing confirmed that pBAB63.1 contained three copies of the 37-bp fragment 
in tandem with the three Pvull sites 37-bp apart. Plasmid pBAB63.11 had two 
copies of the 37-bp fragment in inverted orientation and the two Pvull sites were 34- 
bp apart.
Using a standard gel retardation protocol, cells extracts from the 
restrictionless strain ER1648 (pBAB99), mcrBC, mcrA, mrr, hsdRMS, and the 
McrBC restriction strain ER1564 (pBAB9), mcrA, mrr, hsdRMS were tested for the 
ability to bind the three-site target end-labeled with 32P. To prepare the cell extracts,
EcoRI P v u l l  P v u l l  P v u l l  BamHI
1 ...  1 1 \
□ = = = £ = ................ x = = ....— >
Fig. 11 - The 131-bp target fragm ent of pBAB63.1. Each of the three 37-bp cassettes that make up the 131-bp EcoRl-BamHl 
fragment are in the same orientation. There are 37-bp between each of the three sequential Pvull sites. The sequence of the 37-bp 
cassette is as follows: 5 ’-CCTCTTCGCTATTACGCCAGCTGCATTAATGAATCGG-3’. The Pvull site is underlined.
EcoRI P v u ll  P v u l l  BamHI
1--------------- L _  -  ' t ' |J
<= .  = x  i
Fig. 12 - The 94-bp target fragm ent of pBAB63.11. The two 37-bp cassettes that make up the 94-bp EcoRl-BamHl fragment of 
pBAB63.11 are in opposite orientations. This positions the two Pvull sites 34-bp apart. The sequence of the cassette is the same 
as in Fig. 11.
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cultures were inoculated to an OD600 of approximately 0.2 and grown to stationary 
phase overnight. To prevent McrBC digestion and block other nucleases in the 
extract, EDTA was added to chelate endogenous magnesium ions during the binding 
reaction. No gel shift was observed using cells in early, mid, or late log phase 
growth. The initial gel shift observed was so small that it did not appear to 
represent the bound complex (Fig. 13). However, the barely perceptible shifted 
DNA "band" observed in Lanes 5, 7, and 9 could be competed away with an excess 
of unlabeled methylated target DNA. In addition, the extent of band shift observed 
after 15 min. of electrophoresis was indistinguishable from that present after 2.5 
hours of electrophoresis (data not shown). This was taken as evidence that the 
McrBC complex was extremely labile and quickly denatured upon entering the gel 
matrix or that the gel composition prevented reassociation after initial binding and 
release. Based on this hypothesis, McrBC complex did bind specifically to the DNA 
target and should then be susceptible to cross linking to the target.
UV light at 254nm was used to cross link proteins to DNA in the binding 
reaction. By examining the cross linked complex at various times of exposure to UV 
light, times of 10 or 15 min. were sufficient to accumulate detectable complex (Fig. 
14, Lanes 7, 9, 11, and 14). The complexes were shown to be specific to McrBC- 
containing extracts, resistant to non-methylated competitor target DNA and highly 
susceptible to the methylated target used as an unlabeled competitor. It should be 
noted that competition with unlabeled DNA occurs in the binding reaction prior to 
UV cross linking.
Extract N /A  N/A +  -  + +
Fig. 13 - Gel shift assay. The end labeled 131-bp target fragment of pBAB63.1 was 
used in this assay. Lanes 3, 5, and 7 contain 12, 18, and 24 /ng of extract from 
McrBC" cells, respectively. Lanes 4, 6, and 8 contain 10, 15, and 20 /*g of extract 
from McrBC+ cells, respectively. Lane 1 had no extract added, while Lane 2 was 
empty. The minus (-) and plus (+ )  signs refer to binding reactions using extracts from 
McrBC" and McrBC+ hosts, respectively.
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Lane 1 2 3 4 5 6 7 8 9 10 11 12
Extract - + - + - + - +  + + + +
Min. 0 0 5 5 10 10 15 15 5 5 10 10
Fig. 14 - McrBC-DNA crosslinking with UV light. The end-labeled 131-bp target 
fragment of pBAB63.1 was used in this assay. In the row marked "extract" each (-) 
represents 15 jug extract from a McrBC" host, while each (+ )  represents 15 jug extract 
from a McrBC+ host. The row marked "Min." represents time in minutes for UV 
irradiation. Lanes 9 and 11 had 1.5 jug non-specific competitor DNA added (pUC19), 
while Lanes 10 and 12 had 1.5 jug methylated specific competitor added (pBAB63.1). 
Note the specific McrBC-DNA complex band designated "A".
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The conditions that would permit efficient binding were defined. Weak 
protein-DNA interactions are greatly affected by the ionic conditions of in vitro 
reactions. Maximum, specific binding to the target DNA was observed at 
approximately 50 mM KC1 concentration (Fig. 15). The requirement of GTP for 
McrBC activity has been proposed (76). To see if GTP is necessary for protein 
binding or only for DNA cleavage, binding reactions were set up with GTP added 
to final concentrations of 1.0, 0.5, 0.1, 0.05, and 0.0 mM. As GTP decreased, the 
specific shift cross linked complex became more diffuse and appeared to separate 
into multiple bands (Fig. 16). It should be pointed out that internal cell GTP 
concentrations are approximately 1 mM (13, 76) and, although it is stated that no 
GTP was added to one sample, there was still some amount of diluted cellular GTP. 
To confirm this, when 10 mM MgCl2 was added in the absence of added GTP as in 
Fig. 16, Lane 11, the McrBC-cross linked target fragment band was completely lost, 
while non-specifically cross linked bands were not.
Using the M.PvwII methylated targets, expression of the entire mcrBC operon 
was necessary to see the cross linked complex with cell extracts. The complex was 
not seen from extracts possessing McrBs only, McrBL and McrBs, McrBs and McrC, 
the truncated mcrB gene products expressed by pRA Bll (68) or from McrC alone. 
A weak cross linked complex band was observed with expression of mcrB alone, 
however, these complexes were not tight enough to resist competition with non- 
methylated DNA. This may suggest that McrB, can bind N4-methylcytosine- 
containing DNA but not strongly. This agrees with in vivo restriction and in vitro 
restriction assays which indicate that the entire McrBC complex is needed for
o0.8
m
m 0.6
0.4
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35 52 62 80 100 120
mM KCI concentration
Fig. 15 - Effect of KCI concentration on formation of McrBC-DNA complex bands from the UV cross linking assay. Density 
of exposed silver grains on autoradiograms were quantified in the same axis as electrophoresis. Cumulative density for the McrBC- 
DNA complex is represented in ODnim.
ONo
Lane 1 2 3 4 5 6 7 8 9  10 11
E xtract n /a - + + + + + + + + +
m M  GTP Cone. 1.0 1.0 1.0 1.0 1.0 1.0 0.5 0.1 .05 0.0 0.0
Fig. 16 - Protein-DNA UV cross linked bands obtained as a function of GTP 
concentration. The end labeled 131-bp target fragment of pBAB63.1 was used in this 
assay. In the row marked as Extract, 15 fig extract from a McrBC- host is designated 
as (-) and 15 fig extract from a McrBC+ host is designated as (+ ). Lane 4 contains 0.5 
fig non-specific competitor (pUC19), and Lane 5 contains 0.5 fig methylated 
pBAB63.1. The region of the McrBC-dependent band is marked by "A". Bands "B" 
and "C" were formed with all extracts. Lane 11 received 10 mM MgCl2 to promote 
cleavage of DNA in specific complexes.
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restriction of N4-methylcytosine-containing DNA. For this reason, further analysis 
of DNA binding was done with strains expressing the complete mcrBC operon.
Distinct bands were obtained with the methylated radiolabeled target 
fragments from pBAB63.1 (i.e., containing the three Pvull sites) and pBAB63.11 
(i.e., containing the two-site target fragment) (Fig. 17). When ER1648 (pBAB99) 
extract was used in the cross linking assay no specific complex band was observed. 
ER1564 (pBAB9) extract exhibited an McrBC-dependent band present upon UV 
cross linking. This specific band was not competed by an excess of unlabeled, non- 
methylated target DNA and was eliminated upon competition with an excess of 
unlabeled, methylated target DNA (Fig. 17). This series confirmed that the band 
represented a specific complex between McrBC and the methylated target DNA. 
Proximal Pvull sites in the target fragment of pBAB63.1 are 37-bp apart, while 
distal Pvull sites are 74-bp apart. The Pvull sites in pBAB63.11 are 34-bp apart. 
This indicated that McrBC was either bound to individual methylated sites or bound 
to multiple sites with diverse spacing. Since McrBC-dependent linearization of 
plasmids containing single methylated Pvull sites was observed, single-site target 
fragments (Fig. 18) were tested in the cross linking assay. Interestingly, McrBC- 
dependent cross linking to single-site target DNA fragments was more intense that 
the two- or three-site targets (Fig. 17). However, neither single-site target fragment 
from pBAB61 or pBAB62 gave a defined band. The smeared band was McrBC 
dependent, resistant to non-methylated competitor DNA, and highly sensitive to 
methylated target DNA competitor. It is thought that the active restriction complex 
possesses two DNA binding sites. The smeared bands may represent a combination
E xtract n /a  - +  +  +  n /a  - +  +  +  n /a
Fig. 17 - McrBC-DNA UV cross linking of target fragm ents from  pBAB63.1, 
pBAB63.11, and  pBAB61. Group I consists of the 131-bp target fragment of 
pBAB63.1. Group II consists of the 94-bp target fragment of pBAB63.11, and group 
III consists of the 170-bp target fragment of pBAB61. In the row marked Extract, N/A 
signifies no extract added. The (-) signifies 15 /xg extract from a McrBC" host. The 
(+ )  signifies 15 /xg extract from a McrBC+ host. Lanes 4, 9, and 14 each contain 0.5 
Hg non-specific competitor DNA (pUC19), and Lanes 5, 10, and 15 each contain 0.5 
Hg methylated specific competitor DNA, pBAB63.1, pBAB63.11, and pBAB61 for 
groups I, II, and III, respectively.
pBABGl
E c o RI  P v u l l  B a m l l l
pBAB62
EcoRI P v u l l  BamHI
1_____ -^--------------------------------------------------------------------------------------------- 1-------- 4
Fig. 18 - The single Pv«II site-containing fragments of pBAB61 and pBAB62. The 191-bp EcoRl-BamHl fragment of pBAB61 
possesses one Pvull site situated 70-bp from one end and was derived from pBR322. The 243-bp EcoRl-BamHl fragment of pBAB62 
contains a single Pvull site situated 22-bp from the fragment end. The Pvull site of pBAB62 was the hybrid site created in pBAB99.
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of (i) McrBC molecules cross linked to one or two target DNA molecules, and (ii) 
non-cross linked, gel shift complexes due to protein binding. Together these 
complexes may be visualized as a smear. ODnim readings obtained from Fig. 17 
using densitometry for lanes 12-15 are as follows: Lane 12 - 0.56, Lane 13 - 2.18, 
Lane 14 - 2.13, and Lane 15 - 0.19. These results clearly suggest McrBC-DNA 
complex are present in lanes 13 and 14.
To confirm that DNA containing a single methylated site could bind McrBC, 
single-site targets were used as unlabeled competitor for the labeled two- and three- 
site targets. It was observed that excess methylated pBAB61 (i.e., containing a 
single copy of the hybrid Pvull site found in pBAB99) could be used as specific 
competitor to eliminate a specific McrBC cross linked band, while the same target 
fragment, when non-methylated, did not serve as competitor (results not shown). 
This result confirmed that a single site methylated site could bind McrBC and that 
binding was methylation dependent.
DISCUSSION
M crBC subunit function. The 53-kDa McrBL peptide functions as the 
restriction endonuclease of the McrBC restriction system (23, 24, 36). The 38-kDa 
McrC peptide is necessary for efficient cleavage of most methylated targets (23, 24, 
66). Data supporting these findings were generated using antisense RNA designed 
to lower translation of each peptide. ASR1 caused underexpression of McrBL and 
lowered McrBC and Rgl restriction. This was entirely expected as less endonuclease 
should result in less restriction. ASR3 caused underexpression of McrC and 
concomitantly McrB and Rgl restriction were lowered. Lowered levels of a subunit 
necessary for target recognition was expected to lower McrBC and Rgl restriction. 
ASR3, however, was not expected to lower the McrC-independent McrB* 
restriction. This was shown to be true as JM107 (pASR3), when compared with 
JM107 (pA RV ll), exhibited a decrease in restriction of X.BsuRl but no loss in 
restriction of A.SPR. In addition, mcrBC+ cells possessing ASR1 or ASR3 exhibited 
no secondary effects and appeared normal except for lowered restriction levels. All 
of these facts support existing hypotheses with regards to McrBL and McrC.
Function of M crBs in the McrBC restriction system. The role of McrBs 
was unknown. It has no endonuclease activity alone or with McrC. However, it is 
not possible to mutate McrBs without affecting McrBL. In this study, we were able 
to alter the levels of McrBs without altering McrBL.
The two McrB proteins have been shown experimentally to be expressed in 
approximately equimolar amounts (24, 65, 66). It has also been suggested that 
McrC is expressed at one-third the molar amount of McrBL or McrBs. This 3:3:1
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ratio (McrBL:McrBs:McrC) may serve to set appropriate restriction levels in vivo. 
Our data suggested that the relative amount of McrBs to McrBL or McrC is 
especially relevant. When the level of McrBs relative to McrBL or McrBs was 
dramatically altered, restriction levels were altered. When McrBs was 
overproduced, McrBC and Rgl restriction were diminished or eliminated. The loss 
of restriction correlated with an excess McrBs. Based on Western blots, when 
McrBs was overproduced, the McrBL levels remained constant. Since restriction 
decreased while McrBL levels remained constant, McrBs appeared to inhibit 
restriction at the level of protein-protein interactions. In addition, when McrBs was 
underproduced using ASR2, McrBC and Rgl restriction were disrupted and the SOS 
response was triggered. These findings support the idea that McrBs can interact with 
and inhibit the McrBC complex.
In a host possessing mcrB alone, overproduction of McrBs was also shown 
to diminish McrB* restriction. This suggested that McrBs could interact with McrBL 
since there was no McrC present. This further suggested that McrBs was a 
regulatory protein that disrupted active complex formation. With the thought that 
McrBs could regulate restriction, a series of DNA constructs was made possessing 
sequentially greater truncations of McrBs. The purported McrBs truncations were 
used to study the ability of McrBs to interact with McrBL as measured by McrB* 
restriction. When overproduced in wild-type host (JM107), authentic McrBs caused 
restriction to decrease. The smaller truncations of McrBs caused this peptide to lose 
its ability to inhibit McrBC and McrB* restriction. When assayed for restriction, 
the same host possessing greater truncations of McrBs displayed hyper-restriction.
Hyper-restriction occurred when the smallest of the McrBs-truncated peptides were 
overexpressed and displaced the endogenous McrBs peptide. In the presence of these 
short peptides, the ability of McrBs to modulate formation of active restriction 
complexes was negated and more of the active complexes were formed. This 
phenomenon will be revisited, below, in terms of model development.
McrBs is produced by mcrB from an inframe, internal translational start. 
This results in McrBs possessing an amino acid sequence identical to the carboxyl- 
terminal 65 % of McrBL. There is precedence for regulator proteins produced from 
inframe, internal translation starts. The bacteriophage f l possesses a regulator 
protein produced in this manner (29). The gene II protein product is necessary for 
all f l  DNA synthesis other than the initial synthesis of the complement of the 
incoming (+ )  strand of phage DNA. The gene X protein (C-terminal fragment of 
gene II, started at an inframe AUG within gene II) inhibits gene II protein activity. 
When overexpressed in trans, the gene X protein blocks all phage-specific DNA 
synthesis.
Another example of this phenomenon occurs with the transposon Tn5. It is 
known that transposition of Tn5 is regulated by a peptide produced from an inframe, 
internal translational start of the IS50R mRNA. The full length peptide is a 
transposase, while the 40 amino acids shorter peptide functions as a transposase 
inhibitor (33). By producing the shorter, inhibitory peptide in four times the amount 
of the transposase, transposition is effectively reduced to levels tolerated by the cell. 
Tn5 normally transposes upon introduction to a new host since the shorter, inhibitory 
peptide has not accumulated in the cell. It was shown that the coding region of the
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shorter peptide was sufficient, when produced in trans, to block the transposition of 
newly introduced Tn5. In an analogous fashion, McrBs, when overproduced in 
trans, blocked McrBC activity. And just as unregulated transposition of Tn5 would 
kill the E. coli host, evidence from the present study indicated that unregulated 
McrBC activity damages DNA and induces the SOS response and often cell death.
The favored model for the inhibition of Tn5 transposase by the shorter 
peptide is based on protein-protein interactions and the formation of inactive hetero­
oligomers with the transposase and the shorter peptide. This type of model offers 
the best agreement with the results of the present study of McrBC restriction.
Model describing the interaction of subunits in the McrBC restriction 
system. Interpretation of our data led us to believe that McrBs was a regulator of 
the McrBC restriction system. These findings were also used to construct a model 
to describe the active McrBC restriction complex. The first finding that contributes 
to model development is that McrBs interacts with McrBL, the endonuclease. Based 
on results of McrB* assays, overproduction of McrBs or truncated versions of McrBs 
alter the ability of McrBL to restrict the methylated target DNA in the absence of 
McrC. It is assumed that if McrBs and McrBL interact, McrBL, which contains all 
the amino acids of McrBs, can interact with itself. For this reason we propose that 
McrBL can form minimally a dimer. Since McrBs can disrupt the function of McrBL 
in the McrB* assay, it is proposed that the McrBs-McrBL heterodimer is inactive and 
that the McrBL homodimer is the active endonuclease (Fig. 19).
Relative amounts of McrBL and McrBs in the cell are approximately equal. 
Using the assumption the McrBL and McrBs bind each other equally, simple
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Fig. 19 - Random chance interaction between McrBL and McrBs. McrBL is represented by an ovoid, while McrBs is depicted 
by the white circle. Chance interaction between the subunits displayed would result in the active McrBL homodimer forming 25 % 
of the time. McrBL-McrBs heterodimers and McrBs homodimers are proposed to have no restriction activity.
probability calculations can be used to theorize that 50% of the McrBL subunits will 
be in active McrBL homodimer while the other half will be tied up in non-functional 
heterodimers with McrBs. The remaining McrBs would be found in homodimers 
with itself. Thus of the peptides produced from the mcrB gene, 25 % would be tied 
up in active McrBL-McrBL homodimers, 50% in inactive McrB,-McrBs 
heterodimers, and 25% in inactive McrBs homodimers (Fig. 19). This pattern of 
subunit binding would explain how McrBs is able to modulate or regulate the levels 
of McrBC activity by limiting the amount of active complex formed. This McrBs- 
dependent buffering of McrBC restriction is even more evident when McrC is 
incorporated into the model.
In vitro studies with purified McrBL and McrC (76) suggest that these two 
proteins are required to form an active restriction complex. Our studies suggested 
that McrC can interact with McrBs and McrBL. When McrC was overexpressed in 
JM107, McrBC and Rgl restriction were diminished or eliminated. This indicated 
that McrC can interact with the McrBL-containing active endonuclease complex and 
that too much McrC disrupts this complex. When McrBs and McrC were 
overexpressed together there was no loss of restriction (i.e., restriction rescue 
occurred). This evidence suggests that McrBs and McrC interact. Since McrB, 
contains all the amino acids found in McrBs, it seems likely that these peptides share 
the McrC binding site. The model for subunit interaction predicts that McrC can 
bind each of the McrB complexes proposed in Fig. 19. McrBs would thus 
effectively lower the amount of McrC available to the active McrBL homodimers and 
further serves as a restriction "down regulator" in vivo (Fig. 20). It should be noted
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Fig. 20 - The interaction of M crC with the mcrB gene products. The ovoid figure represents the McrBL subunit. The open circle 
represents McrBs and the filled circle represents McrC. The proposed model specifies that a single McrC monomer interacts with 
the McrBL homodimer to yield the active McrBC complex. Other multimeric complexes binding McrC are inactive.
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that given a McrBL:McrBs:McrC ratio of 3:3:1, only one of the McrBL homodimers 
in three would be predicted to have an McrC subunit bound. Based on the molar 
ratio of subunits, it was initially assumed that one McrC would bind an McrB, 
homodimer to make an active complex. This subunit arrangement of one McrC for 
two McrB subunits would also explain the inhibition of McrBC activity upon 
overexpression of mcrC.
Overexpression of the purported specificity subunit, McrC, lowers McrBC 
and Rgl restriction. The level of McrC needed to disrupt restriction was tested using 
various vectors. Inhibition was observed when mcrC was expressed from pUC8 at 
200 copies/chromosome (pRAB17), pBR322 at 60 copies/chromosome (pBAB56a), 
or pECA310, a pPvuI derivative at 5 copies/chromosome (pBAB46a). This suggests 
that even low levels of McrC overexpression cause loss of restriction. The model 
explains inhibition of McrBC by excess McrC by assuming that each McrB subunit 
has an McrC binding site. The model would predict that the binding of two McrC 
subunits per McrB unit dimer disrupts the complex (Fig. 21). An increase in 
available McrC may allow this subunit either to bind McrBL monomers to create an 
inactive McrBL-McrC complex or that two McrC proteins bind to and inactivate the 
McrBL homodimer.
It is thought that low-level expression of McrC in proper proportion to McrB 
subunits is necessary for maintenance of proper subunit ratios that will yield the 
active restriction complex. One strategy used in nature to insure that the proper 
ratio of proteins is made is translational coupling. Sequence analysis of the mcrB 
and mcrC  genes suggested that McrC synthesis may be translationally coupled to
b
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Fig. 21 - Overexpression of M crC. When McrC, which is represented by the filled circle, is overproduced, restriction loss occurs. 
According to the model, excess McrC binds McrBL monomers preventing dimerization or because two McrC proteins bind the McrB, 
homodimer creating an inactive complex. The ovoid represents McrBL and the open circle represents McrBs.
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McrB (66). In another study efficient overproduction of McrC for purification was 
only achieved when McrC synthesis was translationally coupled to a hybrid McrB 
protein (88). It appears likely that low-level McrC expression is controlled by mcrB- 
mcrC  translational coupling. Given a McrBL:McrBs:McrC ratio of 3:3:1, it is 
thought that 6 peptides must terminate at the end of mcrB ORF for each peptide 
initiated at the mcrC-coding region (67).
A good example where translational coupling regulates expression of a second 
peptide to maintain low levels is the ompB loci. This region consists of the 
translationally coupled ompR and envZ genes. These genes function to regulate outer 
membrane proteins in response to changes in environmental osmolarity. The envZ 
gene produces membrane-bound sensor proteins and must be expressed at low levels. 
Too much expression from envZ makes the cell overly sensitive to environmental 
osmotic changes. Low level expression is insured by translational coupling (50).
Use of the model to explain inhibition of McrBC by overproduction of 
M crBs. The overproduction of McrBs effectively eliminated McrBC restriction as 
assayed by the McrBC assay or the Rgl assay. The proposed model predicts that 
additional McrBs would greatly increase the amount of the inactive McrB, ~McrBs 
heterodimer at the expense of the active McrBL homodimer (Fig. 22). While it is 
true that overproduction of McrBs in JM107 yields loss of restriction, overproduction 
of McrBL and McrBs together yield no such loss. This is because more active and 
inactive complexes are formed in the normal proportion for a net result of slightly 
increased restriction. Since McrC is limiting a large increase in restriction activity 
would not be expected. As stated previously and in keeping with the proposed
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Fig. 22 - Overproduction of the McrBs peptide. The ovoid represents the McrBL subunit, while the open circle represents McrBs. 
The filled circle represents McrC. Restriction loss occurs when McrBs is overproduced. The model states that this peptide in excess 
disrupts active McrBL homodimer formation and shifts the complex formation equilibrium towards a greater number of inactive 
McrBL-McrBs heterodimers. McrBs is also proposed to dimerize and may bind McrC to form inactive complexes.
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model, when McrBs is overproduced in a strain possessing only mcrB, McrB* 
restriction is diminished.
To this point, it has been assumed that McrBL and McrBs bind themselves 
and each other with the same affinity. If these two subunits bind each other equally, 
when pRAB17 was used to overproduce McrBs in the wild-type host JM107, there 
would be virtually no active complex formed. McrBs was thought to be 320-fold in 
excess with JM107 (pRAB17). This would allow a McrBL homodimer to form so 
seldom as to drop restriction below measurable levels. This is not the case as 
restriction 3 fold above the negative control was retained. This evidence suggested 
that the McrBL homodimer is more strongly bound than the McrBs-McrBL 
heterodimer. To facilitate this strongly bound McrBL homodimer, we suggest that 
McrBL proteins contain multiple binding sites for dimerization and that some of these 
binding sites are lacking on the shorter McrBs.
Antisense RNA and the proposed model. Data from antisense RNA 
experiments can now be evaluated with reference to the proposed model for McrBC 
active restriction complex formation and regulation. It is thought that ASR1 simply 
caused a decrease in active complex formation by lowing net McrBL homodimer 
produced. ASR3 produced lowered expression of mcrC and, likewise, lowered 
active complex formation by limiting available McrC from the active McrBL 
homodimer. If this were true, then McrBL homodimer levels should persist and this 
host should maintain McrB* restriction levels in the presence of ASR3. This proved 
to be true. JM107 (pASR3) showed decreased McrBC restriction while showing no 
loss of McrB* restriction. This suggests that ASR3 lowered McrC production only
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and had no effect on mcrB expression. This is also the first report of measurable 
McrB* activity from a chromosomally encoded mcrB gene.
The most dramatic effects observed using antisense RNA were observed using 
ASR2. It was unknown what effect, if any, lowered McrBs amounts would have on 
restriction. Two effects readily evident were: (1) variable restriction levels, and (2) 
slow growing cells that lysed upon serial transfer in broth medium. We believe that 
both of these effects are explained by the lowered McrBs levels. It is thought that 
since less McrBs is available to produce inactive complexes, the number of active 
complexes increases (Fig. 23) causing dramatically increased restriction. This 
restriction activity is postulated to be so excessive that low-level cleavage of non- 
methylated DNA, which is tolerated by the cell under normal conditions, is 
magnified beyond the ability of the cell to repair the damage. Chromosomal DNA 
damage occurs and the SOS response is triggered. SOS response was triggered by 
ASR2 as measured experimentally. This condition leads to non-septated cells that 
readily lyse in broth cultures when shaken. Restriction is lost because this extremely 
deleterious condition is selected against during this highly mutagenic condition. 
Restriction defective strains are selected for and restriction is concomitantly 
measured as low. The variable levels of restriction observed under certain 
conditions is explained by a changing cell population as restriction proficient cells 
are selected against and displaced by restriction defective cells. One way to test this 
result would be to cure JM107 (pASR2) of this plasmid and measure restriction. It 
should be seen that the host remains restriction negative.
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Fig. 23 - Decreasing McrBs synthesis using ASR2 may increase the proportion of active complexes. The ovoid represents McrE^ 
and the open circle represents McrBs. The filled circle represents McrC. This model shows the effect of lowering the number of 
McrBs subunits.
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Hyper-restriction and  the model for M crBC. Data obtained using McrB, 
truncations can be interpreted using the model. It is thought that the active 
restriction complex is a McrBL homodimer and that McrBs causes the formation of 
inactive heterodimers. When McrBs is sufficiently truncated, it performs two 
functions to produce hyper-restriction: (1) Excess truncated McrBs binds to
authentic McrBs to eliminate its ability to bind McrB, and produce inactive 
complexes. (2) Truncated McrBs binds McrBL to block McrBs binding, but still 
allow, due to the greatly diminished size of the truncated proteins, McrBL 
dimerization to form the active complex. The truncated McrBs can block the 
binding site on McrBL necessary for McrBs binding but McrBL can still dimerize 
possibly through the additional binding sites postulated to exist in the.N-terminal end 
of McrBL (Fig. 24). This has the net effect of allowing almost all McrBL monomers 
to be used in active complex formation. Most McrBs is removed from circulation 
because it is bound by the truncated McrBs. Truncated forms of McrBs from 
pBAB74 and pBAB75 are insufficient to block McrBL-McrBL homodimer formation 
and, thus, allow hyper-restriction.
Restriction rescue was taken to represent interaction between McrBs and 
McrC. The longer truncated proteins McrBs271 and McrBs181 contain an adequate 
amount of McrBs to continue to interact with McrC. Of 298 McrBs amino acids, 
234 are truncated to produce McrBs65. McrBs65 has lost its ability to interact with 
McrC. The same is true of McrBs35. It is interesting to note that both McrBs65 
and McrBs35 elicit hyper-restriction in the wild-type background. The failure of 
these truncated proteins to interact with McrC is unlikely to be the cause of hyper-
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Fig. 24 - Truncated McrBs peptides allow hyper-restriction. The ovoid represents McrBL and the open circle represents McrBs. 
The triangle represents truncated McrBs, and the filled circle represents McrC. It is thought that truncated McrBs peptides cause 
hyper-restriction by permitting greater numbers of active complexes to be formed. When the smallest truncated McrBs is present, 
authentic McrBs will be removed from competition freeing essentially all McrBL to form active complexes.
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restriction. This is true because hyper-restriction affects the McrB* assay results for 
DH5<xMCR (pBAB43, pBAB75). In this strain, inability of McrBs35 to interact with 
McrC is irrelevant since it possesses no McrC.
It is interesting to note that restriction of X.O increased slightly when 
assaying DH5aMCR (pBAB43, pBAB75) for McrB* restriction. It should be noted 
that McrC is not present and that other hyper-restrictors where McrC was present 
showed no such gain in restriction of X.O. This suggests that a hyper-restricting 
host in the absence of McrC can restrict DNA lacking traditional McrBC restriction 
recognition sites. It may be that non-methylated target sites are cleaved or that non- 
traditional methylated sites are seen as targets and cleavage occurs. This restriction 
of X.O in the absence of McrC suggests that McrC is indeed a specificity subunit 
and, when lacking in a hyper-restricting strains, allows significant restriction at non- 
traditional sites. This cleavage may always occur in mcrB+C~ mutants but may not 
be measurable. In hyper-restricting strains, elevated levels of restriction permitted 
one to measure methylation-independent restriction. This suggests that McrC 
heightens specificity of the restriction complex for traditional McrBC recognition 
sites.
Binding studies with M crBC. According to the "caging effect" model (28), 
the polyacrylamide gel matrix stabilizes protein-DNA complexes by providing a cage 
so that dissociated protein components cannot diffuse away from the DNA 
throughout the 2-3 hour run time and instead undergo equilibrium binding. This 
model assumes that the protein remains active throughout this run time. This was 
not believed to be so with the McrBC complex. McrBC is known to be highly labile
and may become inactive shortly after entering the gel. Because so little gel shift 
was seen, it became necessary to cross link the protein-DNA complex using UV 
light. Protein-DNA complexes created during the exposure to UV light were joined 
covalently. Upon loading onto the gel, these protein-DNA complexes migrate more 
slowly than unbound DNA fragments and, therefore, can be separated as a 
measurable band. Approximately 15 minutes of UV exposure was seen to be 
adequate to produce this cross linked complex. This assay was performed to see 
which of the McrBC subunits bound DNA. It was found that none could specifically 
bind alone and that the full complex was required to bind the Pvull methylated target 
fragments used.
Once results suggested that McrBs functioned as a regulator protein, models 
were put forth attempting to explain how it might accomplish this. One model, now 
disproven, suggested that McrBs alone or with McrC might bind DNA directly to 
block active complex access to some specific recognition and/or cleavage sites. It 
was found that McrBs alone or with McrC could not bind DNA. This was taken as 
evidence that McrBs regulated restriction by binding to or disrupting a multimeric 
restriction complex made up of at least McrBL.
The optimum KC1 concentration for specific binding was 50 mM. The 
results obtained from this assay suggested that Mg2+ is necessary for cleavage but 
not protein binding. We cannot rule out the possibility that binding may be tighter 
in the presence of Mg2+. Another purportedly required cofactor is GTP although 
there is evidence to believe that ATP may function as a nucleotide cofactor of 
McrBC. Our results suggest that GTP allows protein-DNA binding and as the GTP
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concentrations are lowered, the mobility of the McrBC-DNA band becomes altered. 
It is interesting to note that in the absence of added GTP, the addition of Mg2+ 
allows cleavage of the labeled target fragment. This may be because cellular GTP 
is already bound to an active McrBC complex.
Digestions of specifically methylated plasmids using crude extracts were used 
to test the necessity of ATP or GTP as a McrBC nucleotide cofactor. Our results 
suggest, at least at 0.3 mM conc., that ATP functions equally well as GTP to allow 
restriction. This result is in disagreement with recently published findings that 
suggest McrBC is a GTP-dependent nuclease (57, 76). Our results suggest that 
McrBC is a GTP-utilizing nuclease but that ATP may serve at some concentrations. 
In the Sutherland, et ah (76) study, ATP was never assayed alone and its purported 
inhibitive effect may only have been an effect of total purine nucleotides since GTP 
alone, at high concentrations, inhibited McrBC restriction (76).
During the McrBC-DNA UV cross linking experiment, it was seen that gel 
shift could not be obtained using extracts produced from logrithmically growing 
cells. It is known that the cell contains a concentration of 1 mM GTP and 3 mM 
ATP at this time (13). The ATP-GTP total of 4 mM is well within the range 
reported to result in inhibition of McrBC restriction (76). This could be an allosteric 
inhibition mechanism to keep McrBC restriction to a minimum during active DNA 
replication. We were able to produce the best gel shift results from extracts made 
from cells in stationary phase. This is the phase of growth when ATP and GTP 
concentrations would be low and thus allow McrBC restriction.
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Crude extracts prepared from strains expressing various combinations of 
wild-type and mutated mcrBC genes were used to digest target DNA that possessed 
methylated Pvull sites. We also found that the truncated products produced by 
pR A Bll (40 and 24-kDa) (65) could be complemented by McrC to cleave 5- 
hydroxymethylcytosine (hm5C)-possessing DNA but not 5-methylcytosine (5mC) 
possessing DNA. Extracts made from a pRAB12 (complete mcrB+ truncated McrC) 
possessing host were also adequate to restrict hm5C-containing DNA but not 5mC- 
containing DNA. The McrBC system may be so finely tuned to restriction of lim5C- 
containing DNA that it will even cleave this DNA with significantly truncated McrBL 
(the restriction subunit) or McrC (the specificity subunit). Or hm5C-containing DNA 
of T4 may contain a diverse range of target nucleotide sequences, some of which 
serve as substrates for the modified forms of McrBC.
In vitro analysis of McrBC target sites. In the McrBC-DNA UV cross 
linking assay, labeled DNA target fragment possessing three methylated Pvull sites 
positioned 37-bp apart was primarily used. Specific McrBC-DNA bands could also 
be obtained using target fragments possessing two methylated Pvull sites positioned 
34-bp apart or with fragments with one methylated Pvull site. These results are in 
disagreement with a recently proposed model (76) suggesting a minimum of two 
specific sites positioned 40 - 80-bp apart were necessary to define a specific McrBC 
restriction recognition site. Models for site recognition are limited by the sensitivity 
of the assay used to detect cleavage. It may be that the two site model holds true 
for the specific modified target and restriction cleavage assay used.
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Evidence presented to support the two site model is substantial. However, 
it is important to realize that this model was developed using M.Alul and M.Mspl 
methylated sites and may be correct with respect to these sites. Evidence suggests 
that even identical sites do not elicit DNA cleavage equally (76, this study). If this 
is so, elements in addition to the immediate methylation site must be necessary to 
define an optimal McrBC recognition and cleavage site. Our study was done using 
m4C-containing DNA produced by the Pvull methylase. The m4C or the M.Pvull 
pattern may require different elements to allow McrBC recognition and cleavage than 
does the M.Alul methylase recognition site. The unique traits of the methylation 
pattern of our target DNA may elicit dissimilar results than that seen in the previous 
study. As our findings for defining a McrBC recognition and cleavage site differ 
from the proposed model, it is certain that additional work is needed to further 
define all elements involved. An interesting study may be done using the pBAB61 
insert. This binding site is quite functional and the 170-bp fragment may contain 
additional sequences flanking the Pvull site. Systematic deletions of nucleotides in 
the region flanking this site may yield insight into the true nature of McrBC 
recognition. Recently published results suggest that the McrBC cleavage site is 
proximal to the specific methylation site (76). Our results were in agreement as 
cleavage was achieved with the 131-bp target fragment of pBAB63.1.
In vitro DNA cleavage using crude extracts was used to analyze the 
methylation pattern required to produce a McrBC restriction recognition site. Two 
unique plasmids each possessing a single methylated M.PvwII site were cleaved (Fig. 
18). These results are in agreement with those obtained using target fragments
possessing a single, methylated Pvull site for the McrBC-DNA UV cross linking 
assay. Together, these findings indicate that under the conditions used in this study, 
a single methylated site was sufficient for McrBC binding and target cleavage.
CONCLUSIONS
Significant findings presented in this work are the following:
(1) McrBs is a regulator or modulator of the McrBC restriction system. 
The levels of McrBs were found to affect the results of McrBC, McrB*, and Rgl 
restriction assays. Without functional McrBs, hyper-restriction was observed and 
DNA damage resulting in the induction of the SOS response was documented.
(2) A working model was proposed in which the active restriction 
complex for McrBC and Rgl restriction minimally consists of a McrBL homodimer 
bound by McrC. McrBs forms inactive heterodimers with McrBL and disrupts active 
McrBL homodimers for McrB* restriction and McrBL homodimer-McrC complex for 
McrBC and Rgl restriction.
(3) Based on deletions of the C-terminal coding region of mcrBs, domains 
of McrBs necessary for binding McrBL and McrC were identified.
(4) Data suggest that McrC is the sequence specificity subunit as hyper­
restriction occurring without McrC present allowed low level restriction of DNA 
lacking a traditional restriction target for this system.
(5) Restriction occurred equally well at the concentrations tested using 
ATP or GTP as the nucleotide cofactor. GTP appears to be necessary for protein- 
DNA binding but Mg2+ does not.
(6) One M.PvwII methylated site is adequate for McrBC binding and 
cleavage. Where two M.PvwII methylation sites are present, binding can occur when 
they are as close as 34-bp.
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